Glucocorticoids	O
induce	O
apoptosis	O
in	O
human	B-cell_type
monocytes	I-cell_type
:	O
potential	O
role	O
of	O
IL-1	B-protein
beta	I-protein
.	O

Glucocorticoids	O
(	O
GC	O
)	O
are	O
potent	O
anti-inflammatory	O
and	O
immunosuppressive	O
agents	O
that	O
act	O
on	O
a	O
variety	O
of	O
immune	B-cell_type
cells	I-cell_type
,	O
including	O
monocytes	B-cell_type
and	O
macrophages	B-cell_type
.	O

However	O
,	O
the	O
exact	O
cellular	O
mechanisms	O
underlying	O
this	O
anti-inflammatory	O
capacity	O
are	O
still	O
unknown	O
.	O

In	O
our	O
study	O
,	O
we	O
determined	O
the	O
induction	O
of	O
apoptosis	O
by	O
GC	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

Peripheral	B-cell_type
blood	I-cell_type
monocytes	I-cell_type
were	O
isolated	O
by	O
density	O
centrifugation	O
methods	O
with	O
a	O
purity	O
of	O
>	O
90	O
%	O
and	O
were	O
cultured	O
in	O
RPMI	O
1640	O
medium	O
.	O

Monocyte	O
apoptosis	O
was	O
determined	O
by	O
four	O
independent	O
methods	O
,	O
including	O
annexin-V	O
staining	O
,	O
TUNEL	O
,	O
DNA-laddering	O
,	O
and	O
typical	O
morphology	O
by	O
means	O
of	O
transmission	O
electron	O
microscopy	O
.	O

TNF-alpha	B-protein
and	O
IL-1beta	B-protein
were	O
measured	O
by	O
ELISA	O
.	O

GC	B-protein
receptor	I-protein
was	O
blocked	O
with	O
mifepristone	O
.	O

Caspase	O
3	O
was	O
inhibited	O
with	O
caspase-3	O
inhibitor	O
(	O
DEVD-CHO	O
)	O
.	O

Stimulation	O
with	O
different	O
GC	O
at	O
therapeutic	O
concentrations	O
resulted	O
in	O
monocyte	O
apoptosis	O
in	O
a	O
time-	O
and	O
dose-dependent	O
manner	O
.	O

Necrosis	O
was	O
excluded	O
by	O
propidium	O
iodide	O
staining	O
.	O

Proinflammatory	B-protein
cytokines	I-protein
such	O
as	O
IL-1beta	B-protein
and	O
TNF-alpha	B-protein
were	O
down-regulated	O
by	O
GC	O
treatment	O
.	O

Continuous	O
treatment	O
of	O
monocytes	B-cell_type
with	O
IL-1beta	B-protein
,	O
but	O
not	O
with	O
TNF-alpha	B-protein
,	O
could	O
almost	O
completely	O
prevent	O
GC-induced	O
cell	O
death	O
.	O

The	O
addition	O
of	O
mifepristone	O
or	O
caspase-3	O
inhibitor	O
could	O
partially	O
abrogate	O
GC-induced	O
apoptosis	O
as	O
well	O
as	O
GC-induced	O
inhibition	O
of	O
IL-1beta	B-protein
.	O

This	O
is	O
the	O
first	O
study	O
to	O
demonstrate	O
induction	O
of	O
apoptosis	O
by	O
GC	O
in	O
human	B-cell_type
monocytes	I-cell_type
.	O

GC-induced	O
monocyte	O
apoptosis	O
may	O
be	O
partially	O
mediated	O
through	O
effects	O
on	O
IL-1beta	B-protein
production	O
.	O

It	O
is	O
conceivable	O
that	O
GC	O
exert	O
their	O
anti-inflammatory	O
capacity	O
in	O
various	O
diseases	O
,	O
at	O
least	O
in	O
part	O
,	O
by	O
the	O
induction	O
of	O
apoptosis	O
in	O
monocytes	B-cell_type
.	O

Bioéende	NULL
,	NULL
Boldly	NULL
GolnVivo	NULL
``	NULL
``	NULL
f	NULL
Glucocorticoids	NULL
Induce	NULL
Apoptosis	NULL
in	NULL
Human	NULL
45	NULL
Immunolo	NULL
gy	NULL
Monocytes	NULL
:	NULL
Potential	NULL
Role	NULL
of	NULL
IL-1	NULL
B	NULL
Michael	NULL
Schmidt	NULL
,	NULL
Hans-Gerd	NULL
Pauels	NULL
,	NULL
Norbert	NULL
Liigering	NULL
,	NULL
This	NULL
inf	NULL
{	NULL
lls	NULL
Andreas	NULL
Liigering	NULL
,	NULL
Wolfram	NULL
Domschke	NULL
and	NULL
Torsten	NULL
is	NULL
information	NULL
is	NULL
current	NULL
as	NULL
Kucharzik	NULL
of	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

J	NULL
Immunol	NULL
1999	NULL
;	NULL
163:3484-3490	NULL
;	NULL
;	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/6/3484	NULL
References	NULL
_-	NULL
This	NULL
article	NULL
cites	NULL
35	NULL
articles	NULL
,	NULL
14	NULL
of	NULL
which	NULL
you	NULL
can	NULL
access	NULL
for	NULL
free	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www	NULL
.jimmunol.org/content/163/6/3484	NULL
.	NULL

full	NULL
#	NULL
ref-list-1	NULL
Why	NULL
The	NULL
JT	NULL
?	NULL

Submit	NULL
online	NULL
.	NULL

«	NULL
Rapid	NULL
Reviews	NULL
!	NULL

30	NULL
days*	NULL
from	NULL
submission	NULL
to	NULL
initial	NULL
decision	NULL
*e	NULL
No	NULL
Triage	NULL
!	NULL

Every	NULL
submission	NULL
reviewed	NULL
by	NULL
practicing	NULL
scientists	NULL
*	NULL
Fast	NULL
Publication	NULL
!	NULL

4	NULL
weeks	NULL
from	NULL
acceptance	NULL
to	NULL
publication	NULL
*average	NULL
Subscription	NULL
_	NULL
Information	NULL
about	NULL
subscribing	NULL
to	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/subscription	NULL
Permissions	NULL
_	NULL
Submit	NULL
copyright	NULL
permission	NULL
requests	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.aai.org/About/Publications/Jl/copyright.html	NULL
Email	NULL
Alerts	NULL
_	NULL
Receive	NULL
free	NULL
email-alerts	NULL
when	NULL
new	NULL
articles	NULL
cite	NULL
this	NULL
article	NULL
.	NULL

Sign	NULL
up	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//jimmunol.org/alerts	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
is	NULL
published	NULL
twice	NULL
each	NULL
month	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
,	NULL
Inc.	NULL
,	NULL
1451	NULL
Rockville	NULL
Pike	NULL
,	NULL
Suite	NULL
650	NULL
,	NULL
Rockville	NULL
,	NULL
MD	NULL
20852	NULL
Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
All	NULL
rights	NULL
reserved	NULL
.	NULL

Print	NULL
ISSN	NULL
:	NULL
0022-1767	NULL
Online	NULL
ISSN	NULL
:	NULL
1550-6606	NULL
.	NULL

6107	NULL
'Ot	NULL
Aept	NULL
uo	NULL
1san3	NULL
4g	NULL
/810founwrurt	NULL
[	NULL
'mmmy	NULL
,	NULL
/	NULL
:	NULL
dyy	NULL
wos	NULL
Glucocorticoids	NULL
Induce	NULL
Apoptosis	NULL
in	NULL
Human	NULL
Monocytes	NULL
:	NULL
Potential	NULL
Role	NULL
of	NULL
IL-1B	NULL
Michael	NULL
Schmidt	NULL
,	NULL
*	NULL
Hans-Gerd	NULL
Pauels	NULL
,	NULL
'	NULL
Norbert	NULL
Liigering	NULL
,	NULL
*	NULL
Andreas	NULL
Liigering	NULL
,	NULL
*	NULL
Wolfram	NULL
Domschke	NULL
,	NULL
*	NULL
and	NULL
Torsten	NULL
Kucharzik*	NULL
Glucocorticoids	NULL
(	NULL
GC	NULL
)	NULL
are	NULL
potent	NULL
anti-inflammatory	NULL
and	NULL
immunosuppressive	NULL
agents	NULL
that	NULL
act	NULL
on	NULL
a	NULL
variety	NULL
of	NULL
immune	NULL
cells	NULL
,	NULL
including	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

However	NULL
,	NULL
the	NULL
exact	NULL
cellular	NULL
mechanisms	NULL
underlying	NULL
this	NULL
anti-inflammatory	NULL
capacity	NULL
are	NULL
still	NULL
unknown	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
we	NULL
determined	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
GC	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Peripheral	NULL
blood	NULL
monocytes	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
centrifugation	NULL
methods	NULL
with	NULL
a	NULL
purity	NULL
of	NULL
>	NULL
90	NULL
%	NULL
and	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
.	NULL

Monocyte	NULL
apoptosis	NULL
was	NULL
determined	NULL
by	NULL
four	NULL
independent	NULL
methods	NULL
,	NULL
including	NULL
annexin-V	NULL
staining	NULL
,	NULL
TUNEL	NULL
,	NULL
DNA-laddering	NULL
,	NULL
and	NULL
typical	NULL
morphology	NULL
by	NULL
means	NULL
of	NULL
transmission	NULL
electron	NULL
microscopy	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-1B	NULL
were	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

GC	NULL
receptor	NULL
was	NULL
blocked	NULL
with	NULL
mifepristone	NULL
.	NULL

Caspase	NULL
3	NULL
was	NULL
inhibited	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
(	NULL
DEVD-CHO	NULL
)	NULL
.	NULL

Stimulation	NULL
with	NULL
different	NULL
GC	NULL
at	NULL
therapeutic	NULL
concentrations	NULL
resulted	NULL
in	NULL
monocyte	NULL
apoptosis	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Necrosis	NULL
was	NULL
excluded	NULL
by	NULL
propidium	NULL
iodide	NULL
staining	NULL
.	NULL

Proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1B	NULL
and	NULL
TNF-a	NULL
were	NULL
down-regulated	NULL
by	NULL
GC	NULL
treatment	NULL
.	NULL

Continuous	NULL
treatment	NULL
of	NULL
monocytes	NULL
with	NULL
IL-1	NULL
,	NULL
but	NULL
not	NULL
with	NULL
TNF-a	NULL
,	NULL
could	NULL
almost	NULL
completely	NULL
prevent	NULL
GC-induced	NULL
cell	NULL
death	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
mifepristone	NULL
or	NULL
caspase-3	NULL
inhibitor	NULL
could	NULL
partially	NULL
abrogate	NULL
GC-induced	NULL
apoptosis	NULL
as	NULL
well	NULL
as	NULL
GC-induced	NULL
inhibition	NULL
of	NULL
IL-1	NULL
.	NULL

This	NULL
is	NULL
the	NULL
first	NULL
study	NULL
to	NULL
demonstrate	NULL
induction	NULL
of	NULL
apoptosis	NULL
by	NULL
GC	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

GC-induced	NULL
monocyte	NULL
apoptosis	NULL
may	NULL
be	NULL
partially	NULL
mediated	NULL
through	NULL
effects	NULL
on	NULL
IL-1	NULL
production	NULL
.	NULL

It	NULL
is	NULL
conceivable	NULL
that	NULL
GC	NULL
exert	NULL
their	NULL
anti-inflammatory	NULL
capacity	NULL
in	NULL
various	NULL
diseases	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
Journal	NULL
of	NULL
Immunology	NULL
,	NULL
1999	NULL
,	NULL
163	NULL
:	NULL
3484-3490.	NULL
onocytes	NULL
and	NULL
macrophages	NULL
belong	NULL
to	NULL
the	NULL
main	NULL
effector	NULL
cells	NULL
of	NULL
the	NULL
immune	NULL
system	NULL
,	NULL
because	NULL
they	NULL
play	NULL
a	NULL
cen-	NULL
tral	NULL
role	NULL
in	NULL
the	NULL
initiation	NULL
,	NULL
development	NULL
,	NULL
and	NULL
outcome	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
(	NULL
1	NULL
,	NULL
2	NULL
)	NULL
.	NULL

They	NULL
are	NULL
known	NULL
to	NULL
secrete	NULL
a	NULL
variety	NULL
of	NULL
proinflammatory	NULL
mediators	NULL
such	NULL
as	NULL
TNF-a	NULL
,	NULL
IL-1	NULL
B	NULL
,	NULL
IL-6	NULL
,	NULL
IL-8	NULL
,	NULL
pro-teases	NULL
,	NULL
or	NULL
free	NULL
oxygen	NULL
radicals	NULL
(	NULL
3	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
also	NULL
produce	NULL
anti-inflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-10	NULL
(	NULL
4	NULL
,	NULL
5	NULL
)	NULL
,	NULL
IL-1Ra	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
or	NULL
soluble	NULL
TNF	NULL
receptors	NULL
(	NULL
8	NULL
,	NULL
9	NULL
)	NULL
.	NULL

Peripheral	NULL
monocytes	NULL
as	NULL
well	NULL
as	NULL
differentiated	NULL
tissue	NULL
macrophages	NULL
are	NULL
known	NULL
to	NULL
play	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
inflammatory	NULL
process	NULL
of	NULL
various	NULL
immunomediated	NULL
diseases	NULL
such	NULL
as	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
(	NULL
10	NULL
,	NULL
11	NULL
)	NULL
,	NULL
rheumatoid	NULL
arthritis	NULL
(	NULL
12	NULL
)	NULL
,	NULL
or	NULL
sepsis	NULL
(	NULL
13	NULL
)	NULL
.	NULL

Glucocorticoids	NULL
(	NULL
GC	NULL
)	NULL
°	NULL
are	NULL
potent	NULL
anti-inflammatory	NULL
and	NULL
immunosuppressive	NULL
agents	NULL
that	NULL
act	NULL
on	NULL
many	NULL
cells	NULL
including	NULL
monocytes	NULL
(	NULL
14	NULL
)	NULL
.	NULL

They	NULL
are	NULL
potent	NULL
down-regulators	NULL
of	NULL
monocyte-secreted	NULL
proinflammatory	NULL
mediators	NULL
including	NULL
TNF-a	NULL
(	NULL
15	NULL
,	NULL
16	NULL
)	NULL
,	NULL
IL-1B	NULL
(	NULL
17	NULL
)	NULL
,	NULL
or	NULL
IL-6	NULL
(	NULL
18	NULL
)	NULL
,	NULL
which	NULL
mediate	NULL
inflammatory	NULL
activity	NULL
in	NULL
various	NULL
diseases	NULL
(	NULL
19-21	NULL
)	NULL
.	NULL

However	NULL
,	NULL
the	NULL
exact	NULL
cellular	NULL
mechanisms	NULL
by	NULL
which	NULL
GC	NULL
exert	NULL
their	NULL
anti-inflammatory	NULL
capacity	NULL
in	NULL
monocytes	NULL
are	NULL
only	NULL
incompletely	NULL
understood	NULL
.	NULL

*Department	NULL
of	NULL
Medicine	NULL
B	NULL
,	NULL
*Institute	NULL
for	NULL
Immunology	NULL
,	NULL
University	NULL
of	NULL
Miinster	NULL
,	NULL
Miinster	NULL
,	NULL
Germany	NULL
Received	NULL
for	NULL
publication	NULL
February	NULL
24	NULL
,	NULL
1999	NULL
.	NULL

Accepted	NULL
for	NULL
publication	NULL
July	NULL
13	NULL
,	NULL
1999	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL
'	NULL

This	NULL
work	NULL
was	NULL
supported	NULL
by	NULL
the	NULL
Wilhelm	NULL
Sander-Stiftung	NULL
(	NULL
Miinchen	NULL
,	NULL
Germany	NULL
)	NULL
through	NULL
Grant	NULL
96.046.1	NULL
and	NULL
by	NULL
the	NULL
Interdisciplinary	NULL
Center	NULL
for	NULL
Clinical	NULL
Research	NULL
,	NULL
17KF-D13	NULL
.	NULL

Address	NULL
correspondence	NULL
and	NULL
reprint	NULL
requests	NULL
to	NULL
Dr.	NULL
Torsten	NULL
Kucharzik	NULL
,	NULL
Department	NULL
of	NULL
Medicine	NULL
B	NULL
,	NULL
University	NULL
of	NULL
Miinster	NULL
,	NULL
Albert-Schweitzer-Str	NULL
.	NULL

33	NULL
,	NULL
D-48129	NULL
Miinster	NULL
,	NULL
Germany	NULL
.	NULL

E-mail	NULL
address	NULL
:	NULL
kucharz	NULL
@	NULL
uni-muenster.de	NULL
°	NULL
Abbreviations	NULL
used	NULL
in	NULL
this	NULL
paper	NULL
:	NULL
GC	NULL
,	NULL
glucocorticoid	NULL
(	NULL
s	NULL
)	NULL
;	NULL
PCD	NULL
,	NULL
programmed	NULL
cell	NULL
death	NULL
;	NULL
PI	NULL
,	NULL
propidium	NULL
iodide	NULL
;	NULL
TEM	NULL
,	NULL
transmission	NULL
electron	NULL
microscopy	NULL
.	NULL

Copyright	NULL
©	NULL
1999	NULL
by	NULL
The	NULL
American	NULL
Association	NULL
of	NULL
Immunologists	NULL
Apoptosis	NULL
is	NULL
a	NULL
physiological	NULL
self-destruction	NULL
mechanism	NULL
that	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
endogenous	NULL
program	NULL
and	NULL
signals	NULL
from	NULL
other	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
characterized	NULL
by	NULL
typical	NULL
morphological	NULL
features	NULL
and	NULL
leads	NULL
to	NULL
the	NULL
removal	NULL
of	NULL
the	NULL
dying	NULL
cell	NULL
by	NULL
macrophages	NULL
in	NULL
a	NULL
way	NULL
that	NULL
prevents	NULL
the	NULL
onset	NULL
of	NULL
inflammatory	NULL
reactions	NULL
(	NULL
22	NULL
,	NULL
23	NULL
)	NULL
.	NULL

Monocytes	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
undergo	NULL
rapid	NULL
apoptosis	NULL
in	NULL
culture	NULL
unless	NULL
stimulated	NULL
with	NULL
LPS	NULL
or	NULL
with	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
TNF-a	NULL
or	NULL
IL-1	NULL
,	NULL
which	NULL
enhance	NULL
monocyte	NULL
survival	NULL
by	NULL
omitting	NULL
the	NULL
initiation	NULL
of	NULL
apoptosis	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Recent	NULL
studies	NULL
dealing	NULL
with	NULL
the	NULL
role	NULL
of	NULL
anti-inflammatory	NULL
cytokines	NULL
and	NULL
their	NULL
suppressive	NULL
effects	NULL
on	NULL
monocytes	NULL
demonstrated	NULL
that	NULL
IL-4	NULL
as	NULL
well	NULL
as	NULL
IL-10	NULL
is	NULL
able	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
(	NULL
26	NULL
,	NULL
27	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
was	NULL
postulated	NULL
that	NULL
the	NULL
regulatory	NULL
role	NULL
of	NULL
anti-inflammatory	NULL
cytokines	NULL
in	NULL
the	NULL
development	NULL
of	NULL
inflammatory	NULL
reactions	NULL
also	NULL
involves	NULL
the	NULL
regulation	NULL
of	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
GC	NULL
might	NULL
evoke	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Using	NULL
four	NULL
different	NULL
methods	NULL
for	NULL
the	NULL
determination	NULL
of	NULL
apoptosis	NULL
,	NULL
we	NULL
could	NULL
clearly	NULL
demonstrate	NULL
that	NULL
GC	NULL
at	NULL
therapeutic	NULL
concentrations	NULL
are	NULL
strong	NULL
inducers	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Our	NULL
data	NULL
suggest	NULL
that	NULL
,	NULL
at	NULL
least	NULL
in	NULL
part	NULL
,	NULL
the	NULL
well-known	NULL
anti-inflammatory	NULL
and	NULL
immunosuppressive	NULL
effects	NULL
of	NULL
GC	NULL
on	NULL
monocytes	NULL
and	NULL
macrophages	NULL
are	NULL
mediated	NULL
by	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Abs	NULL
and	NULL
reagents	NULL
PE-conjugated	NULL
mouse	NULL
anti-human	NULL
Leu	NULL
M3	NULL
mAb	NULL
(	NULL
anti-CD14	NULL
,	NULL
clone	NULL
P9	NULL
,	NULL
IgG2b	NULL
)	NULL
and	NULL
control	NULL
mAb	NULL
of	NULL
appropriate	NULL
Ig	NULL
isotype	NULL
were	NULL
obtained	NULL
from	NULL
Becton	NULL
Dickinson	NULL
(	NULL
Palo	NULL
Alto	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

FITC-labeled	NULL
annexin-V	NULL
(	NULL
1/1	NULL
stoichi-ometric	NULL
complex	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Bender	NULL
Medsystems	NULL
(	NULL
Vienna	NULL
,	NULL
Aus-tria	NULL
)	NULL
.	NULL

Caspase-3	NULL
inhibitor	NULL
(	NULL
28-30	NULL
)	NULL
was	NULL
obtained	NULL
from	NULL
Calbiochem	NULL
(	NULL
65812	NULL
Bad	NULL
Soden	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
and	NULL
dexamethasone	NULL
,	NULL
prednisolone	NULL
,	NULL
hydrocortisone	NULL
(	NULL
water-soluble	NULL
)	NULL
,	NULL
mifepristone	NULL
(	NULL
31	NULL
)	NULL
(	NULL
GC	NULL
receptor	NULL
antagonist	NULL
)	NULL
,	NULL
and	NULL
all	NULL
other	NULL
reagents	NULL
were	NULL
obtained	NULL
from	NULL
Sigma	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

0022-1767/99/	NULL
$	NULL
02.00	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Isolation	NULL
and	NULL
culture	NULL
of	NULL
human	NULL
monocytes	NULL
Human	NULL
monocytes	NULL
were	NULL
isolated	NULL
from	NULL
40	NULL
ml	NULL
of	NULL
EDTA-treated	NULL
blood	NULL
,	NULL
drawn	NULL
from	NULL
healthy	NULL
volunteers	NULL
,	NULL
or	NULL
from	NULL
fresh	NULL
leukocyte	NULL
buffy	NULL
coats	NULL
.	NULL

We	NULL
used	NULL
a	NULL
modification	NULL
of	NULL
the	NULL
recently	NULL
described	NULL
hypotonic	NULL
density	NULL
gradient	NULL
centrifugation	NULL
method	NULL
with	NULL
Ficoll	NULL
and	NULL
Percoll	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
mononuclear	NULL
cells	NULL
were	NULL
collected	NULL
from	NULL
the	NULL
interphase	NULL
after	NULL
Ficoll	NULL
separation	NULL
and	NULL
washed	NULL
twice	NULL
in	NULL
PBS	NULL
.	NULL

Subsequently	NULL
,	NULL
cells	NULL
were	NULL
separated	NULL
into	NULL
lymphocytes	NULL
and	NULL
monocytes	NULL
on	NULL
a	NULL
hypotonic	NULL
Percoll	NULL
density	NULL
gradient	NULL
(	NULL
1.129	NULL
g/ml	NULL
)	NULL
.	NULL

From	NULL
the	NULL
two	NULL
interphases	NULL
,	NULL
the	NULL
upper	NULL
interphase	NULL
containing	NULL
the	NULL
monocytes	NULL
was	NULL
collected	NULL
and	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

The	NULL
monocyte	NULL
suspension	NULL
was	NULL
adjusted	NULL
to	NULL
10°	NULL
monocytes/ml	NULL
and	NULL
plated	NULL
on	NULL
24-well	NULL
plates	NULL
(	NULL
Greiner	NULL
,	NULL
Solin-gen	NULL
,	NULL
Germany	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
further	NULL
enriched	NULL
by	NULL
a	NULL
90-min	NULL
adherence	NULL
to	NULL
culture	NULL
plates	NULL
and	NULL
washed	NULL
two	NULL
times	NULL
with	NULL
PBS	NULL
.	NULL

Enriched	NULL
monocytes	NULL
were	NULL
incubated	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
supplemented	NULL
with	NULL
1	NULL
%	NULL
(	NULL
v/v	NULL
)	NULL
heat-inac-tivated	NULL
,	NULL
pooled	NULL
AB	NULL
sera	NULL
(	NULL
complete	NULL
culture	NULL
medium	NULL
)	NULL
for	NULL
24-96	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
to	NULL
10~	NULL
``	NULL
M	NULL
)	NULL
,	NULL
prednisolone	NULL
(	NULL
4	NULL
X	NULL
10~	NULL
``	NULL
to	NULL
4	NULL
X	NULL
10~	NULL
>	NULL
M	NULL
)	NULL
,	NULL
and	NULL
hydrocortisone	NULL
(	NULL
3	NULL
X	NULL
10~°	NULL
to	NULL
3	NULL
X	NULL
10~	NULL
M	NULL
)	NULL
.	NULL

All	NULL
culture	NULL
reagents	NULL
used	NULL
had	NULL
endotoxin	NULL
levels	NULL
of	NULL
<	NULL
0.01	NULL
ng/ml	NULL
LPS	NULL
.	NULL

The	NULL
viability	NULL
of	NULL
the	NULL
monocytes	NULL
was	NULL
>	NULL
95	NULL
%	NULL
as	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
ex-clusion	NULL
;	NULL
purity	NULL
was	NULL
>	NULL
90	NULL
%	NULL
as	NULL
assessed	NULL
by	NULL
flow	NULL
cytometric	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

1A	NULL
)	NULL
and	NULL
nonspecific	NULL
esterase	NULL
staining	NULL
.	NULL

Detection	NULL
of	NULL
annexin-V	NULL
staining	NULL
and	NULL
CD14	NULL
expression	NULL
on	NULL
human	NULL
monocytes	NULL
Monocytes	NULL
,	NULL
prepared	NULL
and	NULL
treated	NULL
as	NULL
described	NULL
above	NULL
,	NULL
were	NULL
double-labeled	NULL
with	NULL
PE-conjugated	NULL
Leu	NULL
M3	NULL
mAb	NULL
(	NULL
anti-CD14	NULL
)	NULL
and	NULL
annexin-V	NULL
FITC	NULL
in	NULL
PBS	NULL
(	NULL
with	NULL
100	NULL
mg/l	NULL
CaCl	NULL
,	NULL
and	NULL
100	NULL
mg/l	NULL
MgC1	NULL
,	NULL
)	NULL
for	NULL
1	NULL
h	NULL
at	NULL
room	NULL
temperature	NULL
in	NULL
the	NULL
dark	NULL
.	NULL

PE-	NULL
and	NULL
FITC-conjugated	NULL
murine	NULL
IgG	NULL
mAbs	NULL
of	NULL
unrelated	NULL
specificities	NULL
were	NULL
always	NULL
used	NULL
as	NULL
controls	NULL
.	NULL

After	NULL
staining	NULL
,	NULL
the	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
measured	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

Determination	NULL
of	NULL
apoptosis	NULL
by	NULL
DNA	NULL
electrophoresis	NULL
DNA	NULL
extraction	NULL
and	NULL
electrophoresis	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
33	NULL
)	NULL
.	NULL

In	NULL
brief	NULL
,	NULL
1	NULL
X	NULL
10	NULL
'	NULL
monocytes	NULL
were	NULL
first	NULL
lysed	NULL
by	NULL
a	NULL
hypotonic	NULL
lysing	NULL
buffer	NULL
(	NULL
10	NULL
mM	NULL
Tris-HCl	NULL
,	NULL
1	NULL
mM	NULL
EDTA	NULL
,	NULL
and	NULL
0.2	NULL
%	NULL
Triton	NULL
X-100	NULL
,	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

After	NULL
centrifugation	NULL
(	NULL
14,000	NULL
X	NULL
g	NULL
,	NULL
30	NULL
min	NULL
)	NULL
supernatants	NULL
containing	NULL
cleaved	NULL
chromatin	NULL
were	NULL
treated	NULL
with	NULL
RNase	NULL
(	NULL
50	NULL
mg/m	NULL
!	NULL
)	NULL

and	NULL
proteinase	NULL
K	NULL
(	NULL
100	NULL
mg/ml	NULL
)	NULL
;	NULL
DNA	NULL
was	NULL
extracted	NULL
by	NULL
phenol/chloroform/isoamylalcohol	NULL
.	NULL

After	NULL
precipitation	NULL
with	NULL
conc	NULL
.	NULL

ethanol	NULL
(	NULL
99.6	NULL
%	NULL
)	NULL
at	NULL
-20°C	NULL
and	NULL
drying	NULL
and	NULL
heating	NULL
of	NULL
samples	NULL
,	NULL
equal	NULL
amounts	NULL
of	NULL
DNA	NULL
were	NULL
loaded	NULL
on	NULL
a	NULL
1.8	NULL
%	NULL
agarose	NULL
gel	NULL
and	NULL
separated	NULL
by	NULL
electrophoresis	NULL
for	NULL
2	NULL
h	NULL
at	NULL
80	NULL
V.	NULL
The	NULL
lower	NULL
detection	NULL
limit	NULL
for	NULL
visualization	NULL
of	NULL
oligonucleosomal	NULL
bands	NULL
was	NULL
1.0	NULL
ug	NULL
of	NULL
DNA	NULL
.	NULL

TUNEL	NULL
procedure	NULL
DNA	NULL
strand	NULL
breaks	NULL
were	NULL
identified	NULL
by	NULL
labeling	NULL
free	NULL
3'-OH	NULL
termini	NULL
with	NULL
modified	NULL
nucleotides	NULL
in	NULL
an	NULL
enzymatic	NULL
reaction	NULL
.	NULL

TdT	NULL
catalyzes	NULL
the	NULL
polymerization	NULL
of	NULL
nucleotides	NULL
to	NULL
free	NULL
3'-OH	NULL
DNA	NULL
ends	NULL
in	NULL
a	NULL
template-independent	NULL
manner	NULL
.	NULL

First	NULL
,	NULL
monocytes	NULL
were	NULL
fixed	NULL
in	NULL
4	NULL
%	NULL
paraformaldehyde	NULL
at	NULL
room	NULL
temperature	NULL
for	NULL
30	NULL
min	NULL
.	NULL

Subsequently	NULL
,	NULL
the	NULL
cytoplasma	NULL
membrane	NULL
was	NULL
per-meabilized	NULL
with	NULL
0.1	NULL
%	NULL
Triton	NULL
X-100	NULL
for	NULL
2	NULL
min	NULL
on	NULL
ice	NULL
.	NULL

In	NULL
the	NULL
next	NULL
step	NULL
,	NULL
DNA	NULL
was	NULL
labeled	NULL
with	NULL
FITC-conjugated	NULL
NTP	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
TdT	NULL
for	NULL
1	NULL
h	NULL
at	NULL
37°C	NULL
.	NULL

After	NULL
labeling	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
twice	NULL
with	NULL
PBS	NULL
and	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
and	NULL
immunofluorescence	NULL
microscopy	NULL
.	NULL

Cells	NULL
labeled	NULL
in	NULL
absence	NULL
of	NULL
TdT	NULL
were	NULL
always	NULL
used	NULL
as	NULL
negative	NULL
controls	NULL
,	NULL
whereas	NULL
cells	NULL
pre-treated	NULL
with	NULL
DNase	NULL
after	NULL
permeabilization	NULL
were	NULL
used	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

Transmission	NULL
electron	NULL
microscopy	NULL
(	NULL
TEM	NULL
)	NULL
Typical	NULL
morphological	NULL
alterations	NULL
indicative	NULL
of	NULL
apoptosis	NULL
were	NULL
evaluated	NULL
by	NULL
TEM	NULL
.	NULL

Cells	NULL
were	NULL
washed	NULL
off	NULL
the	NULL
culture	NULL
plates	NULL
,	NULL
centrifuged	NULL
,	NULL
fixed	NULL
in	NULL
1	NULL
%	NULL
glutaraldehyde/0.1	NULL
M	NULL
sodium	NULL
cacodylate-HCl	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
,	NULL
and	NULL
postfixed	NULL
in	NULL
1	NULL
%	NULL
OsO	NULL
,	NULL
/0.15	NULL
M	NULL
sodium	NULL
cacodylate-HC	NULL
]	NULL
(	NULL
pH	NULL
7.4	NULL
)	NULL
.	NULL

Samples	NULL
were	NULL
dehydrated	NULL
in	NULL
ascending	NULL
ethanol	NULL
series	NULL
and	NULL
embedded	NULL
in	NULL
epoxy	NULL
resin	NULL
(	NULL
Epon	NULL
812	NULL
)	NULL
.	NULL

Ultrathin	NULL
sections	NULL
were	NULL
mounted	NULL
on	NULL
150	NULL
mesh	NULL
Formvar-coated	NULL
copper	NULL
grids	NULL
and	NULL
poststained	NULL
with	NULL
aqueous	NULL
saturated	NULL
uranyl	NULL
acetate	NULL
and	NULL
2	NULL
%	NULL
lead	NULL
citrate	NULL
before	NULL
being	NULL
examined	NULL
on	NULL
a	NULL
Philips	NULL
CM	NULL
10	NULL
electron	NULL
microscope	NULL
(	NULL
Philips	NULL
Electronics	NULL
,	NULL
Mahway	NULL
,	NULL
NJ	NULL
)	NULL
at	NULL
an	NULL
accelerating	NULL
voltage	NULL
of	NULL
60	NULL
kV	NULL
by	NULL
one	NULL
of	NULL
the	NULL
authors	NULL
(	NULL
M.S	NULL
.	NULL
)	NULL

.	NULL

Evaluation	NULL
of	NULL
cell	NULL
necrosis	NULL
The	NULL
viability	NULL
of	NULL
monocytes	NULL
treated	NULL
with	NULL
GC	NULL
was	NULL
determined	NULL
by	NULL
trypan	NULL
blue	NULL
exclusion	NULL
or	NULL
by	NULL
flow	NULL
cytometry	NULL
analysis	NULL
of	NULL
propidium	NULL
iodide	NULL
(	NULL
PT	NULL
)	NULL
uptake	NULL
from	NULL
nonpermeabilized	NULL
cells	NULL
using	NULL
standard	NULL
protocols	NULL
(	NULL
24	NULL
,	NULL
34	NULL
)	NULL
.	NULL

3485	NULL
J	NULL
>	NULL
10+	NULL
93	NULL
%	NULL
G	NULL
O	NULL
.	NULL

M	NULL
-	NULL
2	NULL
]	NULL
(	NULL
dp	NULL
)	NULL
o	NULL
To	NULL
``	NULL
10	NULL
10°	NULL
10	NULL
10°	NULL
CD	NULL
14	NULL
Annexin	NULL
V	NULL
FIGURE	NULL
1	NULL
.	NULL

-	NULL
A	NULL
,	NULL
Monocytes	NULL
were	NULL
isolated	NULL
by	NULL
density	NULL
centrifugation	NULL
methods	NULL
(	NULL
Ficoll	NULL
and	NULL
Percoll	NULL
)	NULL
with	NULL
a	NULL
purity	NULL
of	NULL
>	NULL
90	NULL
%	NULL
and	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
for	NULL
48	NULL
h.	NULL
Cell	NULL
were	NULL
analyzed	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

B	NULL
,	NULL
Effects	NULL
of	NULL
dexamethasone	NULL
on	NULL
monocyte	NULL
annexin-V	NULL
binding	NULL
and	NULL
CD14	NULL
expression	NULL
.	NULL

By	NULL
multiparameter	NULL
flow	NULL
cytometry	NULL
,	NULL
CD14	NULL
expression	NULL
on	NULL
monocytes	NULL
was	NULL
measured	NULL
by	NULL
staining	NULL
with	NULL
PE-labeled	NULL
anti-CD14	NULL
mAb	NULL
Leu	NULL
M3	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
FITC-labeled	NULL
annexin-V.	NULL
Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
for	NULL
48	NULL
h	NULL
or	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
GC	NULL
(	NULL
B	NULL
,	NULL
10~®	NULL
M	NULL
dexamethasone	NULL
;	NULL
C	NULL
,	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
;	NULL
D	NULL
,	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
)	NULL
.	NULL

Compared	NULL
with	NULL
medium	NULL
control	NULL
,	NULL
dexamethasone	NULL
enhanced	NULL
the	NULL
annexin-V	NULL
binding	NULL
followed	NULL
by	NULL
down-regulated	NULL
CD14	NULL
expression	NULL
.	NULL

Cell	NULL
recovery	NULL
was	NULL
94	NULL
+	NULL
4	NULL
%	NULL
after	NULL
48	NULL
h	NULL
and	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
different	NULL
types	NULL
of	NULL
stimulation	NULL
.	NULL

Measurement	NULL
of	NULL
cytokines	NULL
IL-16	NULL
and	NULL
TNF-	NULL
«	NULL
were	NULL
determined	NULL
in	NULL
supernatants	NULL
of	NULL
cultured	NULL
monocytes	NULL
using	NULL
sandwich	NULL
ELISAs	NULL
developed	NULL
by	NULL
Immunotech	NULL
(	NULL
Marseilles	NULL
,	NULL
France	NULL
)	NULL
.	NULL

IL-1	NULL
and	NULL
TNF-a	NULL
ELISAs	NULL
had	NULL
a	NULL
sensitivity	NULL
of	NULL
5	NULL
pg/ml	NULL
.	NULL

A	NULL
standard	NULL
cytokine	NULL
preparation	NULL
(	NULL
recombinant	NULL
cytokine	NULL
with	NULL
defined	NULL
concentration	NULL
)	NULL
was	NULL
used	NULL
as	NULL
internal	NULL
control	NULL
in	NULL
all	NULL
tests	NULL
.	NULL

All	NULL
assays	NULL
were	NULL
tested	NULL
for	NULL
cross-reaction	NULL
by	NULL
adding	NULL
several	NULL
cytokines	NULL
and	NULL
soluble	NULL
receptors	NULL
to	NULL
different	NULL
cytokine	NULL
standards	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
3486	NULL
FIGURE	NULL
2	NULL
.	NULL

Measurement	NULL
of	NULL
apoptosis	NULL
in	NULL
mono-	NULL
A	NULL
cytes	NULL
using	NULL
the	NULL
TUNEL	NULL
method	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
medium	NULL
alone	NULL
(	NULL
A	NULL
)	NULL
for	NULL
48	NULL
h	NULL
or	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
dexamethasone	NULL
concentrations	NULL
(	NULL
B	NULL
,	NULL
10~®	NULL
M	NULL
dexamethasone	NULL
;	NULL
C	NULL
,	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
;	NULL
D	NULL
,	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
)	NULL
and	NULL
examined	NULL
by	NULL
fluorescence	NULL
staining	NULL
as	NULL
well	NULL
as	NULL
by	NULL
FACS	NULL
analysis	NULL
.	NULL

Stimulation	NULL
with	NULL
high	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
D	NULL
)	NULL
induced	NULL
nucleus	NULL
fragmentation	NULL
.	NULL

Apoptosis	NULL
was	NULL
quantified	NULL
in	NULL
parallel	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

The	NULL
open	NULL
histogram	NULL
is	NULL
the	NULL
negative	NULL
control	NULL
,	NULL
stained	NULL
without	NULL
TdT	NULL
,	NULL
whereas	NULL
the	NULL
filled	NULL
histogram	NULL
represents	NULL
TUNEL-stained	NULL
cells	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
an	NULL
enhancement	NULL
of	NULL
TUNEL-positive	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
dexamethasone	NULL
from	NULL
30	NULL
%	NULL
up	NULL
to	NULL
95	NULL
%	NULL
.	NULL

Blocking	NULL
of	NULL
GC	NULL
receptor	NULL
and	NULL
caspase	NULL
3	NULL
Mifepristone	NULL
was	NULL
added	NULL
to	NULL
monocytes	NULL
that	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
.	NULL

(	NULL
Mifepristone	NULL
was	NULL
used	NULL
at	NULL
a	NULL
concentration	NULL
10	NULL
times	NULL
higher	NULL
than	NULL
the	NULL
GC	NULL
to	NULL
block	NULL
the	NULL
GC	NULL
receptor	NULL
)	NULL
(	NULL
31	NULL
)	NULL
.	NULL

To	NULL
inhibit	NULL
caspase	NULL
activity	NULL
,	NULL
we	NULL
added	NULL
a	NULL
caspase-3	NULL
inhibitor	NULL
to	NULL
GC	NULL
-treated	NULL
monocytes	NULL
(	NULL
DEVD-CHO	NULL
,	NULL
10~°	NULL
M	NULL
)	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
staining	NULL
with	NULL
annexin-V	NULL
as	NULL
described	NULL
above	NULL
.	NULL

Statistical	NULL
analysis	NULL
Results	NULL
are	NULL
given	NULL
as	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
.	NULL

For	NULL
statistical	NULL
analysis	NULL
,	NULL
the	NULL
Student	NULL
's	NULL
unpaired	NULL
/	NULL
test	NULL
was	NULL
used	NULL
.	NULL

Statistical	NULL
significance	NULL
was	NULL
considered	NULL
if	NULL
p	NULL
was	NULL
<	NULL
0.05	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
at	NULL
least	NULL
10	NULL
times	NULL
with	NULL
different	NULL
blood	NULL
donors	NULL
,	NULL
unless	NULL
otherwise	NULL
indicated	NULL
.	NULL

Results	NULL
Apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
after	NULL
stimulation	NULL
with	NULL
GC	NULL
Treatment	NULL
with	NULL
GC	NULL
induced	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
monocyte	NULL
apoptosis	NULL
with	NULL
four	NULL
independent	NULL
methods	NULL
.	NULL

By	NULL
measuring	NULL
annexin-V/CD14	NULL
binding	NULL
on	NULL
cell	NULL
surfaces	NULL
and	NULL
TUNEL	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
identify	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
apoptosis	NULL
.	NULL

Agarose	NULL
gel	NULL
electrophoresis	NULL
and	NULL
TEM	NULL
were	NULL
performed	NULL
to	NULL
demonstrate	NULL
the	NULL
late	NULL
stages	NULL
of	NULL
apoptosis	NULL
.	NULL

Using	NULL
FACS	NULL
analysis	NULL
,	NULL
we	NULL
determined	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
annexin-V-positive	NULL
cells	NULL
from	NULL
14	NULL
%	NULL
up	NULL
to	NULL
71	NULL
%	NULL
after	NULL
incubation	NULL
with	NULL
dexamethasone	NULL
at	NULL
different	NULL
concentrations	NULL
and	NULL
a	NULL
decrease	NULL
of	NULL
CD14	NULL
*	NULL
cells	NULL
from	NULL
52	NULL
%	NULL
to	NULL
12	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

1B	NULL
)	NULL
.	NULL

Using	NULL
the	NULL
TUNEL	NULL
method	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
GC-induced	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
by	NULL
fluorescence	NULL
staining	NULL
as	NULL
well	NULL
as	NULL
by	NULL
FACS	NULL
analysis	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Although	NULL
the	NULL
control	NULL
population	NULL
showed	NULL
only	NULL
few	NULL
TUNEL-positive	NULL
cells	NULL
with	NULL
a	NULL
homo-genous	NULL
fluorescent	NULL
nucleus	NULL
,	NULL
almost	NULL
all	NULL
cells	NULL
of	NULL
the	NULL
dexamethasone-treated	NULL
population	NULL
were	NULL
TUNEL-positive	NULL
.	NULL

Stimulation	NULL
with	NULL
a	NULL
high	NULL
dexamethasone	NULL
concentration	NULL
(	NULL
10	NULL
*	NULL
M	NULL
dexamethasone	NULL
)	NULL
induced	NULL
nucleus	NULL
fragmentation	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
quantified	NULL
in	NULL
parallel	NULL
by	NULL
fluorescence	NULL
microscopy	NULL
and	NULL
FACS	NULL
analysis	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
an	NULL
enhancement	NULL
of	NULL
TUNEL-positive	NULL
cells	NULL
after	NULL
stimulation	NULL
with	NULL
dexamethasone	NULL
from	NULL
30	NULL
%	NULL
up	NULL
to	NULL
95	NULL
%	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
we	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
apoptosis	NULL
by	NULL
characteristic	NULL
DNA-laddering	NULL
using	NULL
agarose	NULL
gel	NULL
electrophoresis	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

In	NULL
the	NULL
time	NULL
kinetics	NULL
,	NULL
specific	NULL
DNA-laddering	NULL
could	NULL
be	NULL
shown	NULL
after	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
incubation	NULL
lasting	NULL
for	NULL
>	NULL
72	NULL
h.	NULL
Apoptosis-spe-cific	NULL
laddering	NULL
was	NULL
dose-dependent	NULL
at	NULL
dexamethasone	NULL
concentrations	NULL
of	NULL
107°	NULL
M	NULL
to	NULL
10~*	NULL
M	NULL
after	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
72	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

3B	NULL
)	NULL
.	NULL

Using	NULL
low	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
,	NULL
only	NULL
intact	NULL
genomic	NULL
DNA	NULL
could	NULL
be	NULL
identified	NULL
.	NULL

Morphological	NULL
alterations	NULL
of	NULL
GC-treated	NULL
monocytes	NULL
were	NULL
determined	NULL
by	NULL
TEM	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
,	NULL
A-C	NULL
shows	NULL
normal	NULL
,	NULL
typical	NULL
control	NULL
monocytes	NULL
,	NULL
whereas	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
D-F	NULL
demonstrates	NULL
three	NULL
morphologically	NULL
altered	NULL
monocytes	NULL
stimulated	NULL
with	NULL
107°	NULL
M	NULL
dexamethasone	NULL
.	NULL

Fig	NULL
.	NULL

4	NULL
,	NULL
A-C	NULL
represents	NULL
a	NULL
normal	NULL
GC	NULL
INDUCE	NULL
APOPTOSIS	NULL
IN	NULL
MONOCYTES	NULL
30	NULL
%	NULL
nici	NULL
°	NULL
``	NULL
to	NULL
``	NULL
To	NULL
``	NULL
To	NULL
:	NULL
``	NULL
to	NULL
``	NULL
To	NULL
'	NULL
To	NULL
ass	NULL
60	NULL
%	NULL
o	NULL
=	NULL
to	NULL
f	NULL
80	NULL
%	NULL
os	NULL
To	NULL
.	NULL

|	NULL
BJ	NULL
95	NULL
%	NULL
nucleus-plasma-relation	NULL
with	NULL
a	NULL
predominance	NULL
of	NULL
the	NULL
cytoplasm	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
heterochromatic	NULL
DNA	NULL
in	NULL
the	NULL
nucleus	NULL
and	NULL
intact	NULL
cytoplasmatic	NULL
organelles	NULL
in	NULL
control	NULL
monocytes	NULL
.	NULL

In	NULL
Fig	NULL
.	NULL

4	NULL
,	NULL
D-F	NULL
,	NULL
the	NULL
relation	NULL
between	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
is	NULL
shifted	NULL
to	NULL
the	NULL
nucleus	NULL
.	NULL

In	NULL
GC-treated	NULL
monocytes	NULL
,	NULL
we	NULL
show	NULL
shrunk	NULL
cells	NULL
,	NULL
a	NULL
condensed	NULL
nucleus	NULL
,	NULL
and	NULL
increased	NULL
vacuolization	NULL
of	NULL
the	NULL
cytoplasm	NULL
.	NULL

These	NULL
signs	NULL
are	NULL
typical	NULL
of	NULL
apoptotic	NULL
cells	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
by	NULL
GC	NULL
in	NULL
monocytes	NULL
is	NULL
dose-	NULL
and	NULL
time-dependent	NULL
GC	NULL
induced	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
a	NULL
dose-	NULL
and	NULL
time-dependent	NULL
manner	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
a	NULL
significant	NULL
increase	NULL
of	NULL
annexin-V-positive	NULL
cells	NULL
at	NULL
rising	NULL
dexamethasone	NULL
concentrations	NULL
(	NULL
10	NULL
~®	NULL
M	NULL
to	NULL
10~	NULL
>	NULL
M	NULL
)	NULL
from	NULL
30.3	NULL
%	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
to	NULL
53.7	NULL
%	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
(	NULL
medium	NULL
:	NULL
15.6	NULL
%	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5A	NULL
)	NULL
.	NULL

After	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
48	NULL
h	NULL
,	NULL
we	NULL
noticed	NULL
a	NULL
significant	NULL
increase	NULL
(	NULL
and	NULL
a	NULL
strongly	NULL
significant	NULL
increase	NULL
after	NULL
72	NULL
h	NULL
)	NULL
of	NULL
annexin-V-positive	NULL
monocytes	NULL
.	NULL

Annexin-V-positive	NULL
monocytes	NULL
in	NULL
the	NULL
medium	NULL
were	NULL
21.7	NULL
%	NULL
after	NULL
a	NULL
72-h	NULL
incubation	NULL
,	NULL
whereas	NULL
an	NULL
increase	NULL
was	NULL
found	NULL
in	NULL
the	NULL
dexamethasone-treated	NULL
group	NULL
of	NULL
up	NULL
to	NULL
50.1	NULL
%	NULL
at	NULL
10~°	NULL
M	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
,	NULL
65.05	NULL
%	NULL
at	NULL
10~°	NULL
M	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
,	NULL
and	NULL
69.0	NULL
%	NULL
at	NULL
a	NULL
concentration	NULL
of	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

5B	NULL
)	NULL
.	NULL

A	NULL
B	NULL
L	NULL
0	NULL
24	NULL
48	NULL
72	NULL
96120	NULL
L	NULL
_	NULL
M	NULL
108107104105104	NULL
L	NULL
FIGURE	NULL
3	NULL
.	NULL

-	NULL
Oligonucleosomal	NULL
DNA	NULL
cleavage	NULL
of	NULL
monocytes	NULL
after	NULL
dexamethasone	NULL
treatment	NULL
.	NULL

Electrophoresis	NULL
of	NULL
DNA	NULL
isolated	NULL
from	NULL
1	NULL
X	NULL
10	NULL
``	NULL
monocytes	NULL
was	NULL
performed	NULL
after	NULL
0	NULL
h	NULL
,	NULL
24	NULL
h	NULL
,	NULL
48	NULL
h	NULL
,	NULL
72	NULL
h	NULL
,	NULL
96	NULL
h	NULL
,	NULL
and	NULL
120	NULL
h	NULL
(	NULL
A	NULL
)	NULL
and	NULL
after	NULL
72	NULL
h	NULL
(	NULL
B	NULL
)	NULL
.	NULL

Monocytes	NULL
were	NULL
treated	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
(	NULL
A	NULL
)	NULL
.	NULL

The	NULL
DNA-specific	NULL
laddering	NULL
could	NULL
be	NULL
demonstrated	NULL
after	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
>	NULL
72	NULL
h.	NULL
There	NULL
was	NULL
also	NULL
a	NULL
dose	NULL
dependency	NULL
(	NULL
B	NULL
)	NULL
with	NULL
apoptosis-specific	NULL
laddering	NULL
at	NULL
dexamethasone	NULL
concentrations	NULL
from	NULL
10~°	NULL
M	NULL
to	NULL
10~*	NULL
M	NULL
after	NULL
72	NULL
h	NULL
of	NULL
cell	NULL
culture	NULL
time	NULL
.	NULL

Nucleosomal	NULL
DNA	NULL
fragments	NULL
were	NULL
detected	NULL
by	NULL
ethidium	NULL
bromide	NULL
staining	NULL
.	NULL

A	NULL
m.w	NULL
.	NULL

marker	NULL
of	NULL
a	NULL
100-bp	NULL
DNA	NULL
ladder	NULL
was	NULL
run	NULL
as	NULL
a	NULL
control	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
A	NULL
B	NULL
C	NULL
FIGURE	NULL
4	NULL
.	NULL

Electron	NULL
microscopic	NULL
features	NULL
of	NULL
monocytes	NULL
treated	NULL
with	NULL
GC	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
for	NULL
72	NULL
h	NULL
without	NULL
GC	NULL
(	NULL
A-C	NULL
)	NULL
or	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
(	NULL
D-F	NULL
)	NULL
before	NULL
being	NULL
prepared	NULL
for	NULL
TEM	NULL
.	NULL

In	NULL
the	NULL
control	NULL
population	NULL
,	NULL
nearly	NULL
all	NULL
monocytes	NULL
remained	NULL
intact	NULL
concerning	NULL
morphology	NULL
of	NULL
the	NULL
nucleus	NULL
and	NULL
cytoplasm	NULL
.	NULL

After	NULL
dexamethasone	NULL
treatment	NULL
,	NULL
monocytes	NULL
exhibited	NULL
typical	NULL
signs	NULL
of	NULL
apoptosis	NULL
,	NULL
with	NULL
dense	NULL
nuclear	NULL
condensation	NULL
,	NULL
degeneration	NULL
of	NULL
organelles	NULL
,	NULL
cytoplasmic	NULL
hypervacuol-ization	NULL
,	NULL
and	NULL
loss	NULL
of	NULL
plasma	NULL
membrane	NULL
microvilli	NULL
.	NULL

Magnification	NULL
is	NULL
X	NULL
7200	NULL
.	NULL

Decreased	NULL
apoptosis	NULL
in	NULL
GC-treated	NULL
monocytes	NULL
by	NULL
blocking	NULL
the	NULL
GC	NULL
receptor	NULL
with	NULL
mifepristone	NULL
Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
mifepristone	NULL
(	NULL
10-fold	NULL
higher	NULL
concentration	NULL
than	NULL
the	NULL
GC	NULL
)	NULL
(	NULL
31	NULL
)	NULL
to	NULL
block	NULL
the	NULL
GC	NULL
receptor	NULL
and	NULL
with	NULL
2	NULL
Annexin	NULL
V	NULL
(	NULL
%	NULL
)	NULL
B	NULL
100	NULL
90	NULL
80	NULL
70	NULL
7	NULL
60	NULL
50	NULL
40	NULL
30	NULL
20	NULL
10	NULL
7	NULL
Annexin	NULL
V	NULL
(	NULL
%	NULL
)	NULL
Oh	NULL
24h	NULL
48h	NULL
72h	NULL
time	NULL
(	NULL
h	NULL
)	NULL
FIGURE	NULL
5	NULL
.	NULL

Dose	NULL
dependency	NULL
and	NULL
time	NULL
kinetics	NULL
of	NULL
annexin-V	NULL
binding	NULL
on	NULL
monocytes	NULL
after	NULL
incubation	NULL
with	NULL
GC	NULL
.	NULL

A	NULL
,	NULL
Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
to	NULL
10~	NULL
>	NULL
M	NULL
)	NULL
;	NULL
there	NULL
was	NULL
a	NULL
strong	NULL
dose	NULL
dependency	NULL
of	NULL
annexin-V	NULL
staining	NULL
on	NULL
GC	NULL
concentrations	NULL
.	NULL

B	NULL
,	NULL
Monocytes	NULL
were	NULL
cultured	NULL
with	NULL
dexamethasone	NULL
for	NULL
different	NULL
incubation	NULL
periods	NULL
and	NULL
at	NULL
different	NULL
concentrations	NULL
(	NULL
1078	NULL
M	NULL
,	NULL
10°	NULL
M	NULL
,	NULL
and	NULL
10~+*	NULL
M	NULL
)	NULL
.	NULL

There	NULL
was	NULL
a	NULL
significant	NULL
dependency	NULL
of	NULL
annexin-V	NULL
staining	NULL
on	NULL
the	NULL
time	NULL
of	NULL
incubation	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
from	NULL
10	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
**	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
control	NULL
)	NULL
.	NULL

3487	NULL
®	NULL
control	NULL
c	NULL
mifepristone	NULL
4	NULL
O	NULL
ho	NULL
o	NULL
Annexin	NULL
V	NULL
(	NULL
%	NULL
)	NULL
t	NULL
o	NULL
-a	NULL
o	NULL
o	NULL
Medium	NULL
108	NULL
10°	NULL
Dexamethasone	NULL
(	NULL
mol/l	NULL
)	NULL
FIGURE	NULL
6	NULL
.	NULL

Blocking	NULL
of	NULL
GC	NULL
receptor	NULL
by	NULL
incubation	NULL
with	NULL
mifepristone	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
and	NULL
10~°	NULL
M	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
were	NULL
stimulated	NULL
with	NULL
mifepristone	NULL
(	NULL
at	NULL
a	NULL
10-fold	NULL
greater	NULL
concentration	NULL
than	NULL
the	NULL
GC	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
by	NULL
multicolor	NULL
flow	NULL
cytometry	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
*	NULL
SD	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
control	NULL
)	NULL
;	NULL
+	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
with	NULL
dexamethasone	NULL
without	NULL
mifepristone	NULL
)	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
GC	NULL
receptor	NULL
blockade	NULL
decreased	NULL
GC-induced	NULL
apoptosis	NULL
.	NULL

dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
and	NULL
10~°	NULL
M	NULL
)	NULL
.	NULL

We	NULL
determined	NULL
a	NULL
diminished	NULL
rate	NULL
of	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
that	NULL
were	NULL
cotreated	NULL
with	NULL
GC	NULL
and	NULL
mifepristone	NULL
(	NULL
30.2	NULL
%	NULL
vs	NULL
19.7	NULL
%	NULL
;	NULL
10°	NULL
M	NULL
dexamethasone	NULL
vs	NULL
dexamethasone	NULL
plus	NULL
mifepristone	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Diminished	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
by	NULL
simultaneous	NULL
treatment	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
Monocytes	NULL
were	NULL
costimulated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
,	NULL
10~°	NULL
M	NULL
,	NULL
and	NULL
10~*	NULL
M	NULL
)	NULL
and	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
(	NULL
10~°	NULL
M	NULL
DEVD-CHO	NULL
)	NULL
(	NULL
28-30	NULL
)	NULL
.	NULL

After	NULL
48	NULL
h	NULL
of	NULL
cell	NULL
culture	NULL
,	NULL
apoptosis	NULL
was	NULL
measured	NULL
by	NULL
annexin-V	NULL
staining	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
GC-induced	NULL
apoptosis	NULL
was	NULL
diminished	NULL
in	NULL
monocytes	NULL
that	NULL
were	NULL
treated	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
(	NULL
30.2	NULL
%	NULL
stimulated	NULL
with	NULL
10~®	NULL
M	NULL
dexamethasone	NULL
vs	NULL
16.4	NULL
%	NULL
treated	NULL
with	NULL
10~®	NULL
M	NULL
dexamethasone	NULL
plus	NULL
DEVD-CHO	NULL
;	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
.	NULL

Continuous	NULL
treatment	NULL
with	NULL
IL-1B	NULL
prevents	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
and	NULL
stimulated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
,	NULL
10~°	NULL
M	NULL
,	NULL
and	NULL
10	NULL
~*	NULL
M	NULL
)	NULL
.	NULL

Cells	NULL
were	NULL
further	NULL
treated	NULL
with	NULL
proinflammatory	NULL
cytokines	NULL
(	NULL
50	NULL
U/ml	NULL
TNF-a	NULL
,	NULL
50	NULL
U/ml	NULL
IL-1	NULL
,	NULL
and	NULL
50	NULL
U/ml	NULL
TNF-a	NULL
plus	NULL
50	NULL
U/ml	NULL
IL-1	NULL
$	NULL
)	NULL
every	NULL
8	NULL
h.	NULL
Apoptosis	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometry	NULL
.	NULL

W	NULL
contro	NULL
!	NULL

D	NULL
Caspase-3-inhibitor	NULL
DEVD-CHO	NULL
Annexin	NULL
V	NULL
(	NULL
%	NULL
)	NULL
Dexamethasone	NULL
(	NULL
mol/l	NULL
)	NULL
FIGURE	NULL
7	NULL
.	NULL

-	NULL
Effect	NULL
of	NULL
caspase-3	NULL
inhibitor	NULL
on	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

Monocytes	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
,	NULL
10~°	NULL
M	NULL
,	NULL
and	NULL
10~+*	NULL
M	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
were	NULL
stimulated	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
.	NULL

Apoptosis	NULL
was	NULL
measured	NULL
by	NULL
multicolor	NULL
flow	NULL
cytometry	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
control	NULL
)	NULL
;	NULL
+	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
without	NULL
caspase-3	NULL
inhibitor	NULL
stimulation	NULL
)	NULL
.	NULL

The	NULL
GC-induced	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
could	NULL
be	NULL
partially	NULL
blocked	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
3488	NULL
80	NULL
70	NULL
I	NULL
Control	NULL
ary	NULL
@	NULL
TNF	NULL
&	NULL
697	NULL
loma	NULL
=	NULL
>	NULL
50	NULL
|	NULL
|	NULL
@	NULL
TNE+IL-1	NULL
£	NULL
%	NULL
u	NULL
C	NULL
c	NULL
La	NULL
<	NULL
4	NULL
x	NULL
*	NULL
*	NULL
*	NULL
LJ	NULL
Medium	NULL
108	NULL
108	NULL
104	NULL
Dexamethasone	NULL
(	NULL
mol/l	NULL
)	NULL
FIGURE	NULL
8	NULL
.	NULL

Effect	NULL
of	NULL
IL-1B	NULL
and	NULL
TNF-	NULL
«	NULL
on	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

Cells	NULL
were	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
and	NULL
stimulated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
they	NULL
were	NULL
treated	NULL
with	NULL
TNF-	NULL
«	NULL
,	NULL
IL-1	NULL
,	NULL
and	NULL
TNF-a	NULL
plus	NULL
IL-1	NULL
B	NULL
(	NULL
50	NULL
U/ml	NULL
for	NULL
each	NULL
cytokine	NULL
)	NULL
every	NULL
8	NULL
h.	NULL
Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
from	NULL
five	NULL
independent	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
with	NULL
control	NULL
)	NULL
.	NULL

The	NULL
continuous	NULL
addition	NULL
of	NULL
IL-1B	NULL
(	NULL
or	NULL
the	NULL
combination	NULL
of	NULL
IL-16	NULL
plus	NULL
TNF-a	NULL
,	NULL
but	NULL
not	NULL
TNF-a	NULL
alone	NULL
)	NULL
significantly	NULL
decreased	NULL
GC-induced	NULL
apoptosis	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
continuous	NULL
stimulation	NULL
with	NULL
IL-1B	NULL
almost	NULL
completely	NULL
prevented	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

The	NULL
monocyte	NULL
apoptosis	NULL
induced	NULL
by	NULL
different	NULL
concentrations	NULL
of	NULL
GC	NULL
decreased	NULL
after	NULL
treatment	NULL
with	NULL
IL-1	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

In	NULL
con-trast	NULL
,	NULL
treatment	NULL
with	NULL
TNF-a	NULL
induced	NULL
no	NULL
changes	NULL
or	NULL
even	NULL
an	NULL
increase	NULL
of	NULL
apoptosis	NULL
.	NULL

Comparison	NULL
of	NULL
different	NULL
GC	NULL
preparations	NULL
on	NULL
induction	NULL
of	NULL
monocyte	NULL
apoptosis	NULL
We	NULL
examined	NULL
different	NULL
GC	NULL
with	NULL
regard	NULL
to	NULL
their	NULL
capacity	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
.	NULL

Prednisolone	NULL
,	NULL
hydrocortisone	NULL
,	NULL
and	NULL
dexamethasone	NULL
were	NULL
tested	NULL
by	NULL
the	NULL
same	NULL
relative	NULL
concentrations	NULL
according	NULL
to	NULL
their	NULL
biological	NULL
strength	NULL
in	NULL
human	NULL
compartments	NULL
.	NULL

The	NULL
cell	NULL
culture	NULL
incubation	NULL
period	NULL
for	NULL
these	NULL
experiments	NULL
was	NULL
48	NULL
h.	NULL
All	NULL
drugs	NULL
induced	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
(	NULL
Fig	NULL
.	NULL

9	NULL
)	NULL
.	NULL

After	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
48	NULL
h	NULL
,	NULL
we	NULL
determined	NULL
90	NULL
-I	NULL
D	NULL
Dexamethasone	NULL
**	NULL
80	NULL
-I	NULL
.	NULL

Prednisolone	NULL
Hydrocortisone	NULL
Annexin	NULL
V	NULL
(	NULL
%	NULL
)	NULL
a	NULL
o	NULL
060	NULL
20	NULL
0	NULL
Medium	NULL
:	NULL
_	NULL
A	NULL
Glucocorticoids	NULL
FIGURE	NULL
9	NULL
.	NULL

Comparison	NULL
of	NULL
different	NULL
GC	NULL
preparations	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

Prednisolone	NULL
,	NULL
hydrocortisone	NULL
,	NULL
and	NULL
dexamethasone	NULL
were	NULL
tested	NULL
using	NULL
the	NULL
same	NULL
relative	NULL
concentrations	NULL
according	NULL
to	NULL
their	NULL
biological	NULL
strength	NULL
in	NULL
human	NULL
compartments	NULL
(	NULL
A	NULL
,	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
,	NULL
4	NULL
X	NULL
10~®	NULL
M	NULL
prednisolone	NULL
,	NULL
and	NULL
3	NULL
X	NULL
10~	NULL
'	NULL
M	NULL
hydrocortisone	NULL
;	NULL
B	NULL
,	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
,	NULL
4	NULL
X	NULL
10~°	NULL
M	NULL
prednisolone	NULL
,	NULL
and	NULL
3	NULL
X	NULL
10~°	NULL
M	NULL
hydrocortisone	NULL
;	NULL
C	NULL
,	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
,	NULL
4	NULL
X	NULL
10~*	NULL
M	NULL
prednisolone	NULL
,	NULL
and	NULL
3	NULL
X	NULL
10~	NULL
``	NULL
M	NULL
hydrocortisone	NULL
)	NULL
.	NULL

All	NULL
GC	NULL
preparations	NULL
induced	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
**	NULL
p	NULL
<	NULL
0.01	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
control	NULL
)	NULL
.	NULL

GC	NULL
INDUCE	NULL
APOPTOSIS	NULL
IN	NULL
MONOCYTES	NULL
A	NULL
A	NULL
B	NULL
i	NULL
&	NULL
a	NULL
H	NULL
90	NULL
%	NULL
w	NULL
91	NULL
%	NULL
m	NULL
A	NULL
=	NULL
10	NULL
10	NULL
10°	NULL
10	NULL
to	NULL
``	NULL
Pio	NULL
so	NULL
-	NULL
to	NULL
10°	NULL
to*	NULL
|	NULL
e	NULL
==	NULL
C	NULL
D	NULL
88	NULL
%	NULL
..	NULL
89	NULL
%	NULL
.	NULL

,	NULL
,	NULL
10	NULL
~	NULL
aso	NULL
-	NULL
ao	NULL
``	NULL
to	NULL
-	NULL
to	NULL
10°	NULL
do	NULL
-	NULL
do	NULL
-	NULL
10°	NULL
fo	NULL
Propidium	NULL
lodide	NULL
FIGURE	NULL
10	NULL
.	NULL

Exclusion	NULL
of	NULL
necrosis	NULL
by	NULL
PI	NULL
staining	NULL
.	NULL

Cell	NULL
necrosis	NULL
of	NULL
monocytes	NULL
cultured	NULL
for	NULL
48	NULL
h	NULL
after	NULL
stimulation	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
was	NULL
measured	NULL
by	NULL
PI	NULL
staining	NULL
during	NULL
FACS	NULL
analysis	NULL
(	NULL
A	NULL
,	NULL
medium	NULL
control	NULL
;	NULL
B	NULL
,	NULL
10~®	NULL
M	NULL
dexamethasone	NULL
;	NULL
C	NULL
,	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
;	NULL
D	NULL
,	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
)	NULL
.	NULL

Filled	NULL
histograms	NULL
represent	NULL
monocytes	NULL
treated	NULL
with	NULL
different	NULL
dexamethasone	NULL
concentrations	NULL
.	NULL

Open	NULL
histograms	NULL
representing	NULL
monocytes	NULL
with	NULL
permeable	NULL
cytoplasma	NULL
membrane	NULL
served	NULL
as	NULL
a	NULL
positive	NULL
control	NULL
.	NULL

There	NULL
was	NULL
no	NULL
significant	NULL
difference	NULL
between	NULL
PI-negative	NULL
monocytes	NULL
in	NULL
any	NULL
experiment	NULL
.	NULL

the	NULL
following	NULL
annexin-V-positive	NULL
monocytes	NULL
:	NULL
medium	NULL
:	NULL
15.6	NULL
%	NULL
;	NULL
concentration	NULL
B	NULL
:	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
at	NULL
29.3	NULL
%	NULL
,	NULL
4	NULL
X	NULL
10~°	NULL
M	NULL
prednisolone	NULL
at	NULL
25.8	NULL
%	NULL
,	NULL
and	NULL
3	NULL
X	NULL
10~°	NULL
M	NULL
hydrocortisone	NULL
at	NULL
36.0	NULL
%	NULL
(	NULL
p	NULL
<	NULL
0.05	NULL
)	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
control	NULL
)	NULL
.	NULL

After	NULL
stimulation	NULL
with	NULL
higher	NULL
concentrations	NULL
of	NULL
GC	NULL
(	NULL
concentration	NULL
C	NULL
:	NULL
10	NULL
~*	NULL
M	NULL
dexamethasone	NULL
,	NULL
4	NULL
X	NULL
10~*	NULL
M	NULL
prednisolone	NULL
,	NULL
and	NULL
3	NULL
X	NULL
10~°	NULL
M	NULL
hydro-cortisone	NULL
)	NULL
,	NULL
there	NULL
was	NULL
also	NULL
a	NULL
strongly	NULL
significant	NULL
induction	NULL
of	NULL
apoptosis	NULL
(	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
.	NULL

Exclusion	NULL
of	NULL
necrosis	NULL
by	NULL
PI	NULL
staining	NULL
The	NULL
exclusion	NULL
of	NULL
necrotic	NULL
cell	NULL
death	NULL
is	NULL
essential	NULL
for	NULL
the	NULL
demonstration	NULL
of	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
PCD	NULL
)	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
,	NULL
monocytes	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
dexamethasone	NULL
concentrations	NULL
for	NULL
48	NULL
h	NULL
in	NULL
cell	NULL
culture	NULL
and	NULL
stained	NULL
with	NULL
PI	NULL
.	NULL

Untreated	NULL
monocytes	NULL
with	NULL
permeable	NULL
cytoplasma	NULL
membrane	NULL
served	NULL
as	NULL
positive	NULL
controls	NULL
.	NULL

As	NULL
shown	NULL
in	NULL
Fig	NULL
.	NULL

10	NULL
treatment	NULL
with	NULL
various	NULL
doses	NULL
of	NULL
dexamethasone	NULL
failed	NULL
to	NULL
increase	NULL
PI	NULL
staining	NULL
compared	NULL
with	NULL
controls	NULL
(	NULL
filled	NULL
histo-gram	NULL
)	NULL
.	NULL

After	NULL
a	NULL
48-h	NULL
incubation	NULL
,	NULL
we	NULL
found	NULL
90	NULL
%	NULL
PI-negative	NULL
monocytes	NULL
in	NULL
the	NULL
control	NULL
medium	NULL
,	NULL
whereas	NULL
the	NULL
ratio	NULL
was	NULL
91	NULL
%	NULL
in	NULL
monocytes	NULL
treated	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
,	NULL
88	NULL
%	NULL
in	NULL
monocytes	NULL
treated	NULL
with	NULL
10~°	NULL
M	NULL
dexamethasone	NULL
,	NULL
and	NULL
89	NULL
%	NULL
in	NULL
cells	NULL
stimulated	NULL
with	NULL
10	NULL
~*	NULL
M	NULL
dexamethasone	NULL
.	NULL

Decreased	NULL
monocyte	NULL
production	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
after	NULL
treatment	NULL
with	NULL
GC	NULL
To	NULL
examine	NULL
the	NULL
influence	NULL
of	NULL
GC	NULL
on	NULL
cytokine	NULL
production	NULL
,	NULL
we	NULL
performed	NULL
ELISAs	NULL
of	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
in	NULL
cell	NULL
culture	NULL
supernatants	NULL
.	NULL

Monocytes	NULL
were	NULL
incubated	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
as	NULL
well	NULL
as	NULL
with	NULL
mifepristone	NULL
and	NULL
caspase-3	NULL
inhibitor	NULL
for	NULL
48	NULL
h.	NULL
We	NULL
noticed	NULL
a	NULL
down-regulation	NULL
of	NULL
cytokine	NULL
production	NULL
depending	NULL
upon	NULL
GC	NULL
concentrations	NULL
(	NULL
Table	NULL
I	NULL
)	NULL
.	NULL

After	NULL
an	NULL
incubation	NULL
period	NULL
of	NULL
48	NULL
h	NULL
,	NULL
a	NULL
strong	NULL
decrease	NULL
of	NULL
TNF-a	NULL
(	NULL
64.0	NULL
+	NULL
15.1	NULL
%	NULL
to	NULL
29.2	NULL
+	NULL
13.4	NULL
%	NULL
;	NULL
control	NULL
vs	NULL
10~*	NULL
M	NULL
dexamethasone	NULL
;	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
and	NULL
of	NULL
IL-1	NULL
B	NULL
(	NULL
327.6	NULL
+	NULL
38.2	NULL
to	NULL
126.1	NULL
+	NULL
20.3	NULL
;	NULL
control	NULL
vs	NULL
10	NULL
~*	NULL
M	NULL
dexamethasone	NULL
;	NULL
p	NULL
<	NULL
0.01	NULL
)	NULL
was	NULL
evident	NULL
.	NULL

Incubation	NULL
with	NULL
mifepristone	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
The	NULL
Journal	NULL
of	NULL
Immunology	NULL
Table	NULL
I	NULL
.	NULL

_	NULL
Down-regulation	NULL
of	NULL
proinflammatory	NULL
cytokines	NULL
by	NULL
GC	NULL
3489	NULL
TNF-a	NULL
(	NULL
pg/ml	NULL
)	NULL
IL-1	NULL
B	NULL
(	NULL
pg/m1	NULL
)	NULL
IL-1	NULL
B	NULL
(	NULL
pg/m1	NULL
)	NULL
IL-1	NULL
(	NULL
pg/ml	NULL
)	NULL
Medium	NULL
64.0	NULL
+	NULL
15.1	NULL
327.6	NULL
+	NULL
38.2	NULL
Medium	NULL
plus	NULL
351.3	NULL
+	NULL
42.8	NULL
Medium	NULL
plus	NULL
342.8	NULL
+	NULL
37.6	NULL
caspase-3	NULL
mifepristone	NULL
inhibitor	NULL
GC	NULL
(	NULL
10-8	NULL
M	NULL
)	NULL
46.7	NULL
+	NULL
6.5	NULL
%	NULL
291.7	NULL
+	NULL
29.3	NULL
GC	NULL
10~®	NULL
M	NULL
321.4	NULL
+	NULL
37.8	NULL
GC	NULL
10~°	NULL
M	NULL
plus	NULL
311.7	NULL
+	NULL
25.1	NULL
plus	NULL
caspase-3	NULL
mifepristone	NULL
inhibitor	NULL
GC	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
35.6	NULL
+	NULL
9.9**	NULL
172.1	NULL
+	NULL
49.4**	NULL
GC	NULL
10~°	NULL
M	NULL
274.2	NULL
+	NULL
GC	NULL
10~°	NULL
M	NULL
plus	NULL
299.7	NULL
+	NULL
51.9¢	NULL
plus	NULL
caspase-3	NULL
mifepristone	NULL
inhibitor	NULL
GC	NULL
(	NULL
107+	NULL
M	NULL
)	NULL
29.2	NULL
£	NULL
13.4**	NULL
126.1	NULL
+	NULL
20.3**	NULL
GC	NULL
10~+*	NULL
M	NULL
178.9	NULL
+	NULL
31.5*f	NULL
plus	NULL
caspase-3	NULL
inhibitor	NULL
``	NULL
Monocytes	NULL
were	NULL
cultured	NULL
in	NULL
RPMI	NULL
1640	NULL
medium	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
dexamethasone	NULL
for	NULL
48	NULL
h.	NULL
Cytokines	NULL
were	NULL
measured	NULL
in	NULL
culture	NULL
supernatants	NULL
by	NULL
ELISAs	NULL
.	NULL

TNF-a	NULL
and	NULL
IL-1	NULL
8	NULL
could	NULL
be	NULL
significantly	NULL
down-regulated	NULL
by	NULL
GC	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

After	NULL
costimulation	NULL
with	NULL
mifepristone	NULL
or	NULL
caspase-3	NULL
inhibitor	NULL
,	NULL
the	NULL
GC	NULL
effect	NULL
on	NULL
IL-1	NULL
B	NULL
production	NULL
by	NULL
monocytes	NULL
could	NULL
be	NULL
partially	NULL
abrogated	NULL
.	NULL

*	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
;	NULL
**	NULL
,	NULL
p	NULL
<	NULL
0.01	NULL
(	NULL
compared	NULL
with	NULL
medium	NULL
)	NULL
¢	NULL
,	NULL
p	NULL
<	NULL
0.05	NULL
(	NULL
compared	NULL
without	NULL
caspase-3	NULL
inhibitor	NULL
or	NULL
without	NULL
mifepristone	NULL
)	NULL
.	NULL

Data	NULL
represent	NULL
means	NULL
+	NULL
SD	NULL
,	NULL
n	NULL
=	NULL
10	NULL
.	NULL

(	NULL
107°	NULL
M	NULL
)	NULL
partially	NULL
diminished	NULL
the	NULL
effects	NULL
of	NULL
GC	NULL
on	NULL
IL-1	NULL
production	NULL
by	NULL
monocytes	NULL
compared	NULL
with	NULL
cells	NULL
treated	NULL
with	NULL
dexamethasone	NULL
(	NULL
10~°	NULL
M	NULL
)	NULL
alone	NULL
(	NULL
299.7	NULL
pg/ml	NULL
IL-1B	NULL
vs	NULL
172.1	NULL
pg/ml	NULL
IL-1	NULL
)	NULL
.	NULL

Caspase-3	NULL
inhibition	NULL
(	NULL
caspase-3	NULL
inhibitor	NULL
,	NULL
10~°	NULL
M	NULL
)	NULL
also	NULL
partially	NULL
abrogated	NULL
the	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
IL-1	NULL
(	NULL
3	NULL
secretion	NULL
in	NULL
monocytes	NULL
compared	NULL
with	NULL
dexamethasone	NULL
(	NULL
107°	NULL
M	NULL
)	NULL
-treated	NULL
cells	NULL
alone	NULL
(	NULL
274.2	NULL
pg/ml	NULL
vs	NULL
172.1	NULL
pg/ml	NULL
IL-1B	NULL
)	NULL
.	NULL

Discussion	NULL
This	NULL
is	NULL
the	NULL
first	NULL
study	NULL
demonstrating	NULL
that	NULL
GC	NULL
at	NULL
therapeutic	NULL
concentrations	NULL
(	NULL
dexamethasone	NULL
from	NULL
10~®	NULL
M	NULL
to	NULL
10~°	NULL
M	NULL
)	NULL
can	NULL
evoke	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
in	NULL
a	NULL
time-	NULL
and	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Monocytes	NULL
and	NULL
macrophages	NULL
belong	NULL
to	NULL
one	NULL
of	NULL
the	NULL
main	NULL
immune	NULL
cell	NULL
populations	NULL
that	NULL
are	NULL
involved	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
inflammatory	NULL
disorders	NULL
.	NULL

The	NULL
immunosuppressive	NULL
and	NULL
anti-inflammatory	NULL
actions	NULL
of	NULL
GC	NULL
are	NULL
mediated	NULL
through	NULL
actions	NULL
on	NULL
different	NULL
cell	NULL
types	NULL
,	NULL
including	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

These	NULL
effects	NULL
are	NULL
brought	NULL
about	NULL
by	NULL
the	NULL
suppression	NULL
of	NULL
secretion	NULL
of	NULL
various	NULL
cytokines	NULL
,	NULL
including	NULL
TNF-a	NULL
and	NULL
IL-1	NULL
$	NULL
,	NULL
which	NULL
contribute	NULL
to	NULL
the	NULL
immune	NULL
and	NULL
inflammatory	NULL
activities	NULL
of	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

Induction	NULL
of	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
as	NULL
a	NULL
potential	NULL
immu-nomodulating	NULL
mechanism	NULL
of	NULL
GC	NULL
has	NULL
not	NULL
yet	NULL
been	NULL
described	NULL
.	NULL

In	NULL
the	NULL
present	NULL
study	NULL
,	NULL
the	NULL
apoptotic	NULL
effects	NULL
of	NULL
GC	NULL
on	NULL
highly	NULL
purified	NULL
populations	NULL
of	NULL
human	NULL
monocytes	NULL
have	NULL
been	NULL
determined	NULL
by	NULL
four	NULL
different	NULL
methods	NULL
.	NULL

As	NULL
marker	NULL
for	NULL
early	NULL
apoptosis	NULL
,	NULL
we	NULL
performed	NULL
binding	NULL
studies	NULL
with	NULL
annexin-V	NULL
,	NULL
which	NULL
was	NULL
bound	NULL
on	NULL
apoptotic	NULL
monocytes	NULL
.	NULL

A	NULL
significant	NULL
increase	NULL
of	NULL
annexin-V-positive	NULL
monocytes	NULL
after	NULL
stimulation	NULL
with	NULL
dexamethasone	NULL
was	NULL
observed	NULL
.	NULL

TUNEL	NULL
also	NULL
became	NULL
strongly	NULL
positive	NULL
in	NULL
monocytes	NULL
treated	NULL
with	NULL
GC	NULL
in	NULL
a	NULL
dose-dependent	NULL
manner	NULL
.	NULL

Later	NULL
on	NULL
by	NULL
means	NULL
of	NULL
TEM	NULL
,	NULL
GC-treated	NULL
monocytes	NULL
revealed	NULL
typical	NULL
morphological	NULL
signs	NULL
of	NULL
apoptosis	NULL
,	NULL
such	NULL
as	NULL
cytoplasmic	NULL
hypervacuolization	NULL
and	NULL
chromatin	NULL
condensation	NULL
of	NULL
the	NULL
nucleus	NULL
.	NULL

Apoptosis	NULL
was	NULL
further	NULL
confirmed	NULL
by	NULL
characteristic	NULL
ladder	NULL
patterns	NULL
in	NULL
DNA	NULL
electrophoresis	NULL
.	NULL

Monocyte	NULL
necrosis	NULL
could	NULL
be	NULL
excluded	NULL
using	NULL
PI	NULL
staining	NULL
.	NULL

In	NULL
our	NULL
study	NULL
,	NULL
we	NULL
used	NULL
GC	NULL
concentrations	NULL
from	NULL
10~°	NULL
M	NULL
to	NULL
10~°	NULL
M	NULL
,	NULL
which	NULL
are	NULL
reached	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
acute	NULL
or	NULL
chronic	NULL
inflammatory	NULL
diseases	NULL
.	NULL

To	NULL
exclude	NULL
the	NULL
different	NULL
properties	NULL
of	NULL
various	NULL
types	NULL
of	NULL
GC	NULL
,	NULL
dexamethasone	NULL
,	NULL
prednisolone	NULL
,	NULL
and	NULL
hydrocortisone	NULL
were	NULL
examined	NULL
.	NULL

When	NULL
we	NULL
compared	NULL
the	NULL
relative	NULL
concentrations	NULL
of	NULL
these	NULL
GC	NULL
depending	NULL
upon	NULL
their	NULL
biological	NULL
strength	NULL
,	NULL
we	NULL
could	NULL
not	NULL
find	NULL
any	NULL
significant	NULL
difference	NULL
concerning	NULL
their	NULL
apoptogenic	NULL
capacity	NULL
.	NULL

We	NULL
could	NULL
further	NULL
demonstrate	NULL
a	NULL
diminished	NULL
induction	NULL
of	NULL
apoptosis	NULL
after	NULL
cotreatment	NULL
with	NULL
the	NULL
GC	NULL
receptor	NULL
antagonist	NULL
mifepristone	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
conclude	NULL
that	NULL
there	NULL
is	NULL
a	NULL
direct	NULL
receptor-medi-ated	NULL
effect	NULL
of	NULL
GC	NULL
on	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

GC-induced	NULL
monocyte	NULL
apoptosis	NULL
could	NULL
also	NULL
be	NULL
partially	NULL
blocked	NULL
by	NULL
treatment	NULL
with	NULL
caspase-3	NULL
inhibitor	NULL
.	NULL

Caspase-3	NULL
is	NULL
a	NULL
main	NULL
enzyme	NULL
in	NULL
the	NULL
apoptosis-signaling	NULL
pathway	NULL
that	NULL
deactivates	NULL
poly	NULL
(	NULL
ADP-ribose	NULL
)	NULL
-polymerase	NULL
and	NULL
therefore	NULL
seems	NULL
to	NULL
be	NULL
involved	NULL
in	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

Until	NULL
now	NULL
,	NULL
the	NULL
exact	NULL
mechanisms	NULL
of	NULL
the	NULL
immunosuppressive	NULL
activity	NULL
of	NULL
GC	NULL
were	NULL
unknown	NULL
.	NULL

It	NULL
is	NULL
likely	NULL
that	NULL
multiple	NULL
modes	NULL
of	NULL
action	NULL
exist	NULL
(	NULL
35	NULL
)	NULL
.	NULL

High-affinity	NULL
GC	NULL
receptors	NULL
have	NULL
been	NULL
identified	NULL
in	NULL
earlier	NULL
studies	NULL
(	NULL
36	NULL
)	NULL
.	NULL

Monocytopenia	NULL
(	NULL
37	NULL
)	NULL
as	NULL
well	NULL
as	NULL
diminished	NULL
chemotaxis	NULL
and	NULL
decreased	NULL
antimicrobial	NULL
activity	NULL
have	NULL
been	NULL
described	NULL
elsewhere	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
it	NULL
could	NULL
be	NULL
demonstrated	NULL
that	NULL
monocyte-derived	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
,	NULL
IL-6	NULL
,	NULL
and	NULL
TNF-a	NULL
are	NULL
suppressed	NULL
by	NULL
GC	NULL
(	NULL
9	NULL
,	NULL
17	NULL
,	NULL
38	NULL
)	NULL
.	NULL

Down-regulation	NULL
of	NULL
the	NULL
proinflammatory	NULL
cytokines	NULL
TNF-a	NULL
and	NULL
IL-1B	NULL
by	NULL
GC	NULL
has	NULL
also	NULL
been	NULL
determined	NULL
in	NULL
our	NULL
monocyte	NULL
culture	NULL
system	NULL
.	NULL

Recently	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
suggested	NULL
that	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
IL-1	NULL
B	NULL
and	NULL
TNF-a	NULL
exert	NULL
anti-apoptotic	NULL
effects	NULL
as	NULL
they	NULL
rescue	NULL
monocytes	NULL
from	NULL
undergoing	NULL
apoptosis	NULL
and	NULL
prolong	NULL
survival	NULL
of	NULL
monocytes	NULL
(	NULL
24	NULL
,	NULL
25	NULL
)	NULL
.	NULL

Down-regulation	NULL
of	NULL
anti-apoptotic	NULL
mediators	NULL
such	NULL
as	NULL
TNF-a	NULL
or	NULL
IL-1B	NULL
as	NULL
determined	NULL
in	NULL
our	NULL
study	NULL
may	NULL
promote	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
.	NULL

We	NULL
were	NULL
able	NULL
to	NULL
demonstrate	NULL
that	NULL
continuous	NULL
treatment	NULL
with	NULL
IL-1	NULL
B	NULL
,	NULL
in	NULL
contrast	NULL
to	NULL
TNF-a	NULL
,	NULL
almost	NULL
completely	NULL
prevents	NULL
GC-induced	NULL
apoptosis	NULL
.	NULL

Therefore	NULL
,	NULL
IL-1B	NULL
seems	NULL
to	NULL
have	NULL
important	NULL
an-tiapoptotic	NULL
properties	NULL
,	NULL
and	NULL
it	NULL
is	NULL
conceivable	NULL
that	NULL
the	NULL
observed	NULL
effects	NULL
of	NULL
GC-induced	NULL
monocyte	NULL
apoptosis	NULL
are	NULL
mediated	NULL
through	NULL
effects	NULL
of	NULL
GC	NULL
inhibition	NULL
of	NULL
IL-1	NULL
production	NULL
.	NULL

However	NULL
,	NULL
the	NULL
partial	NULL
reversal	NULL
of	NULL
GC-induced	NULL
IL-1	NULL
3	NULL
inhibition	NULL
of	NULL
caspase-3	NULL
antagonism	NULL
implies	NULL
that	NULL
apoptosis	NULL
is	NULL
required	NULL
for	NULL
full	NULL
inhibition	NULL
of	NULL
IL-1	NULL
B	NULL
.	NULL

This	NULL
suggests	NULL
a	NULL
direct	NULL
effect	NULL
of	NULL
apoptosis	NULL
on	NULL
IL-1B	NULL
production	NULL
rather	NULL
than	NULL
these	NULL
effects	NULL
being	NULL
exclusively	NULL
in	NULL
the	NULL
reverse	NULL
direction	NULL
.	NULL

In	NULL
activated	NULL
immune	NULL
cells	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
apoptosis	NULL
may	NULL
be	NULL
an	NULL
additional	NULL
important	NULL
mechanism	NULL
by	NULL
which	NULL
GC	NULL
to	NULL
exert	NULL
their	NULL
anti-inflammatory	NULL
properties	NULL
.	NULL

There	NULL
are	NULL
several	NULL
reports	NULL
demonstrating	NULL
that	NULL
immunosuppressive	NULL
agents	NULL
,	NULL
including	NULL
GC	NULL
,	NULL
induce	NULL
apoptosis	NULL
in	NULL
T	NULL
lymphocytes	NULL
(	NULL
39	NULL
,	NULL
40	NULL
)	NULL
,	NULL
whereas	NULL
no	NULL
study	NULL
deals	NULL
with	NULL
GC-induced	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
PCD	NULL
by	NULL
immunosuppressive	NULL
or	NULL
anti-inflammatory	NULL
cytokines	NULL
has	NULL
recently	NULL
been	NULL
described	NULL
by	NULL
others	NULL
.	NULL

IL-4	NULL
,	NULL
a	NULL
T	NULL
cell-derived	NULL
cytokine	NULL
that	NULL
acts	NULL
on	NULL
monocytes	NULL
,	NULL
as	NULL
well	NULL
as	NULL
6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL
3490	NULL
IL-10	NULL
,	NULL
have	NULL
been	NULL
shown	NULL
to	NULL
induce	NULL
apoptosis	NULL
in	NULL
peripheral	NULL
monocytes	NULL
(	NULL
26	NULL
,	NULL
27	NULL
,	NULL
33	NULL
)	NULL
.	NULL

PCD	NULL
as	NULL
evoked	NULL
in	NULL
monocytes	NULL
by	NULL
immunosuppressive	NULL
agents	NULL
such	NULL
as	NULL
steroids	NULL
or	NULL
anti-inflammatory	NULL
cytokines	NULL
may	NULL
therefore	NULL
be	NULL
an	NULL
important	NULL
mechanism	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
immunomediated	NULL
diseases	NULL
,	NULL
in	NULL
addition	NULL
to	NULL
the	NULL
well	NULL
known	NULL
monocyte	NULL
deactivating	NULL
effects	NULL
of	NULL
these	NULL
mediators	NULL
.	NULL

Following	NULL
steroid	NULL
treatment	NULL
,	NULL
systemic	NULL
monocytopenia	NULL
may	NULL
be	NULL
a	NULL
consequence	NULL
of	NULL
an	NULL
increased	NULL
rate	NULL
of	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
monocytes	NULL
by	NULL
GC	NULL
may	NULL
have	NULL
two	NULL
contrasting	NULL
effects	NULL
.	NULL

During	NULL
the	NULL
state	NULL
of	NULL
inflammation	NULL
,	NULL
the	NULL
induction	NULL
of	NULL
PCD	NULL
in	NULL
highly	NULL
activated	NULL
monocytes	NULL
,	NULL
which	NULL
secrete	NULL
a	NULL
variety	NULL
of	NULL
mediators	NULL
maintaining	NULL
inflammation	NULL
,	NULL
may	NULL
have	NULL
therapeutic	NULL
benefit	NULL
.	NULL

The	NULL
disadvantage	NULL
of	NULL
monocyte	NULL
apoptosis	NULL
,	NULL
however	NULL
,	NULL
may	NULL
be	NULL
that	NULL
potent	NULL
immune	NULL
cells	NULL
belonging	NULL
to	NULL
the	NULL
mononuclear	NULL
phagocyte	NULL
system	NULL
will	NULL
be	NULL
eliminated	NULL
.	NULL

Consequently	NULL
,	NULL
an	NULL
increased	NULL
risk	NULL
of	NULL
infectious	NULL
diseases	NULL
may	NULL
develop	NULL
in	NULL
patients	NULL
treated	NULL
with	NULL
GC	NULL
.	NULL

All	NULL
in	NULL
all	NULL
,	NULL
our	NULL
data	NULL
suggest	NULL
that	NULL
induction	NULL
of	NULL
apoptosis	NULL
in	NULL
human	NULL
monocytes	NULL
appears	NULL
to	NULL
be	NULL
an	NULL
important	NULL
way	NULL
for	NULL
GC	NULL
to	NULL
exert	NULL
their	NULL
anti-inflammatory	NULL
and	NULL
immunosuppressive	NULL
properties	NULL
.	NULL

The	NULL
monocyte	NULL
apoptosis	NULL
induced	NULL
by	NULL
immunosuppressive	NULL
agents	NULL
such	NULL
as	NULL
GC	NULL
may	NULL
regulate	NULL
cell	NULL
number	NULL
at	NULL
the	NULL
inflammatory	NULL
site	NULL
and	NULL
also	NULL
reduce	NULL
release	NULL
of	NULL
toxic	NULL
mediators	NULL
into	NULL
systemic	NULL
circulation	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Adams	NULL
,	NULL
D.	NULL
O.	NULL
,	NULL
and	NULL
T.	NULL
A.	NULL
Hamilton	NULL
.	NULL

1984	NULL
.	NULL

The	NULL
cell	NULL
biology	NULL
of	NULL
macrophage	NULL
acti-vation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

2:283	NULL
.	NULL

2	NULL
.	NULL

Solbach	NULL
,	NULL
W.	NULL
,	NULL
H.	NULL
Moll	NULL
,	NULL
and	NULL
M.	NULL
Rollinghoff	NULL
.	NULL

1991	NULL
.	NULL

Lymphocytes	NULL
play	NULL
the	NULL
music	NULL
but	NULL
macrophages	NULL
call	NULL
the	NULL
tune	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
12:4	NULL
.	NULL

3	NULL
.	NULL

Munoz	NULL
,	NULL
C.	NULL
,	NULL
J.	NULL
Carlet	NULL
,	NULL
C.	NULL
Fitting	NULL
,	NULL
B.	NULL
Misset	NULL
,	NULL
J.	NULL
P.	NULL
Bleriot	NULL
,	NULL
and	NULL
J.	NULL
M.	NULL
Cavaillon	NULL
.	NULL

Dysregulation	NULL
of	NULL
in	NULL
vitro	NULL
cytokine	NULL
production	NULL
by	NULL
monocytes	NULL
during	NULL
sepsis	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

88:1747	NULL
.	NULL

4	NULL
.	NULL

Kucharzik	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Liigering	NULL
,	NULL
G.	NULL
Winde	NULL
,	NULL
W.	NULL
Domschke	NULL
,	NULL
and	NULL
R.	NULL
Stoll	NULL
.	NULL

1997	NULL
.	NULL

Colon	NULL
carcinoma	NULL
cell	NULL
lines	NULL
stimulate	NULL
monocytes	NULL
and	NULL
lamina	NULL
propria	NULL
mononuclear	NULL
cells	NULL
to	NULL
produce	NULL
IL-10	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

110:296	NULL
.	NULL

5	NULL
.	NULL

Yoshida	NULL
,	NULL
Y.	NULL
,	NULL
K.	NULL
Kang	NULL
,	NULL
M.	NULL
Berger	NULL
,	NULL
G.	NULL
Chen	NULL
,	NULL
A.	NULL
C.	NULL
Gilliam	NULL
,	NULL
A.	NULL
Moser	NULL
,	NULL
L.	NULL
Wu	NULL
,	NULL
C.	NULL
Hammerberg	NULL
,	NULL
and	NULL
K.	NULL
D.	NULL
Cooper	NULL
.	NULL

Monocyte	NULL
induction	NULL
of	NULL
IL-10	NULL
and	NULL
down-regulation	NULL
of	NULL
IL-12	NULL
by	NULL
C3b	NULL
deposited	NULL
in	NULL
ultraviolet-exposed	NULL
human	NULL
skin	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:5873	NULL
.	NULL

6	NULL
.	NULL

Arend	NULL
,	NULL
W.	NULL
P.	NULL
,	NULL
H.	NULL
G.	NULL
Wegus	NULL
,	NULL
R.	NULL
C.	NULL
Thompson	NULL
,	NULL
and	NULL
S.	NULL
P.	NULL
Eisenberg	NULL
.	NULL

1990	NULL
.	NULL

Biological	NULL
properties	NULL
of	NULL
recombinant	NULL
human	NULL
monocyte-derived	NULL
interleukin	NULL
1	NULL
receptor	NULL
antagonist	NULL
.	NULL

J.	NULL
Clin	NULL
.	NULL

Invest	NULL
.	NULL

85:1694	NULL
.	NULL

7	NULL
.	NULL

Arzt	NULL
,	NULL
E.	NULL
,	NULL
J.	NULL
Sauer	NULL
,	NULL
and	NULL
T.	NULL
Pollmacher	NULL
.	NULL

1994	NULL
.	NULL

Glucocorticoids	NULL
suppress	NULL
interleu-kin-1	NULL
receptor	NULL
antagonist	NULL
synthesis	NULL
following	NULL
induction	NULL
by	NULL
endotoxin	NULL
.	NULL

Endocri-nology	NULL
134:672	NULL
.	NULL

8	NULL
.	NULL

Dickensheets	NULL
,	NULL
H.	NULL
L.	NULL
,	NULL
S.	NULL
L.	NULL
Freeman	NULL
,	NULL
M.	NULL
F.	NULL
Smith	NULL
,	NULL
and	NULL
R.	NULL
P.	NULL
Donnelly	NULL
.	NULL

Interleukin-10	NULL
upregulates	NULL
TNF	NULL
receptor	NULL
type-II	NULL
(	NULL
p75	NULL
)	NULL
gene	NULL
expression	NULL
in	NULL
endotoxin-stimulated	NULL
human	NULL
monocytes	NULL
.	NULL

Blood	NULL
90:4162	NULL
.	NULL

9	NULL
.	NULL

Joyce	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
A.	NULL
Kloda	NULL
,	NULL
and	NULL
J.	NULL
H.	NULL
Steer	NULL
.	NULL

1997	NULL
.	NULL

Dexamethasone	NULL
suppresses	NULL
release	NULL
of	NULL
soluble	NULL
TNF	NULL
receptors	NULL
by	NULL
human	NULL
monocytes	NULL
concurrently	NULL
with	NULL
TNF-a	NULL
sup-pression	NULL
.	NULL

Immunol	NULL
.	NULL

Cell	NULL
Biol	NULL
.	NULL

75:345	NULL
.	NULL

10	NULL
.	NULL

Kucharzik	NULL
,	NULL
T.	NULL
,	NULL
N.	NULL
Liigering	NULL
,	NULL
H.	NULL
Weigelt	NULL
,	NULL
M.	NULL
Adolf	NULL
,	NULL
W.	NULL
Domschke	NULL
,	NULL
and	NULL
R.	NULL
Stoll	NULL
.	NULL

1996	NULL
.	NULL

Immunoregulatory	NULL
properties	NULL
of	NULL
IL-13	NULL
in	NULL
patients	NULL
with	NULL
inflammatory	NULL
bowel	NULL
disease	NULL
:	NULL
comparison	NULL
with	NULL
IL-4	NULL
and	NULL
IL-10	NULL
.	NULL

Clin	NULL
.	NULL

Exp	NULL
.	NULL

Immunol	NULL
.	NULL

104:483	NULL
.	NULL

11	NULL
.	NULL

Yao	NULL
,	NULL
K.	NULL
,	NULL
A.	NULL
Iwashita	NULL
,	NULL
T.	NULL
Yao	NULL
,	NULL
S.	NULL
Takemura	NULL
,	NULL
K.	NULL
Furukawa	NULL
,	NULL
T.	NULL
Matsui	NULL
,	NULL
and	NULL
K.	NULL
Aoyagi	NULL
.	NULL

1996	NULL
.	NULL

Increased	NULL
numbers	NULL
of	NULL
macrophages	NULL
in	NULL
noninflamed	NULL
gastrodu-odenal	NULL
mucosa	NULL
of	NULL
patients	NULL
with	NULL
Crohn	NULL
's	NULL
disease	NULL
.	NULL

Dig	NULL
.	NULL

Dis	NULL
.	NULL

Sci	NULL
.	NULL

11:2260	NULL
.	NULL

12	NULL
.	NULL

Hart	NULL
,	NULL
P.	NULL
H.	NULL
,	NULL
M.	NULL
J.	NULL
Ahern	NULL
,	NULL
M.	NULL
D.	NULL
Smith	NULL
,	NULL
and	NULL
J.	NULL
J.	NULL
Finlay-Jones	NULL
.	NULL

1995	NULL
.	NULL

Comparison	NULL
of	NULL
the	NULL
suppressive	NULL
effects	NULL
of	NULL
interleukin-10	NULL
and	NULL
interleukin-4	NULL
on	NULL
synovial	NULL
fluid	NULL
macrophages	NULL
and	NULL
blood	NULL
monocytes	NULL
from	NULL
patients	NULL
with	NULL
inflammatory	NULL
arthritis	NULL
.	NULL

Immunology	NULL
84:536	NULL
.	NULL

13	NULL
.	NULL

Hensler	NULL
,	NULL
T.	NULL
,	NULL
C.	NULL
D.	NULL
Heidecke	NULL
,	NULL
H.	NULL
Hecker	NULL
,	NULL
K.	NULL
Heeg	NULL
,	NULL
H.	NULL
Bartels	NULL
,	NULL
N.	NULL
Zant	NULL
,	NULL
H.	NULL
Wagner	NULL
,	NULL
J.	NULL
R.	NULL
Siewert	NULL
,	NULL
and	NULL
B.	NULL
Holzmann	NULL
.	NULL

1998	NULL
.	NULL

Increased	NULL
susceptibility	NULL
to	NULL
postoperative	NULL
sepsis	NULL
in	NULL
patients	NULL
with	NULL
impaired	NULL
monocyte	NULL
IL-12	NULL
production	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

161:2655	NULL
.	NULL

14	NULL
.	NULL

15	NULL
.	NULL

16	NULL
.	NULL

17	NULL
.	NULL

18	NULL
.	NULL

19	NULL
.	NULL

20	NULL
.	NULL

21	NULL
.	NULL

22	NULL
.	NULL

23	NULL
.	NULL

24	NULL
.	NULL

25	NULL
.	NULL

26	NULL
.	NULL

27	NULL
.	NULL

28	NULL
.	NULL

29	NULL
.	NULL

30	NULL
.	NULL

31	NULL
.	NULL

32	NULL
.	NULL

33	NULL
.	NULL

34	NULL
.	NULL

35	NULL
.	NULL

36	NULL
.	NULL

37	NULL
.	NULL

38	NULL
.	NULL

39	NULL
.	NULL

40	NULL
.	NULL

GC	NULL
INDUCE	NULL
APOPTOSIS	NULL
IN	NULL
MONOCYTES	NULL
Fauci	NULL
,	NULL
A.	NULL
S.	NULL
,	NULL
D.	NULL
C.	NULL
Dale	NULL
,	NULL
and	NULL
J.	NULL
E.	NULL
Balow	NULL
.	NULL

1976	NULL
.	NULL

Glucocorticosteroid	NULL
therapy	NULL
:	NULL
mechanisms	NULL
of	NULL
action	NULL
and	NULL
clinical	NULL
considerations	NULL
.	NULL

Ann	NULL
.	NULL

Intern	NULL
.	NULL

Med	NULL
.	NULL

84:304	NULL
.	NULL

Han	NULL
,	NULL
J.	NULL
,	NULL
P.	NULL
Thompson	NULL
,	NULL
and	NULL
B.	NULL
Beutler	NULL
.	NULL

1990	NULL
.	NULL

Dexamethasone	NULL
and	NULL
pentoxifylline	NULL
inhibit	NULL
endotoxin-induced	NULL
cachectin/tumor	NULL
necrosis	NULL
factor	NULL
synthesis	NULL
at	NULL
separate	NULL
points	NULL
in	NULL
the	NULL
signaling	NULL
pathway	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

172:391	NULL
.	NULL

Joyce	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
J.	NULL
H.	NULL
Steer	NULL
,	NULL
and	NULL
L.	NULL
J.	NULL
Abraham	NULL
.	NULL

1997	NULL
.	NULL

Glucocorticoid	NULL
modulation	NULL
of	NULL
human	NULL
monocyte/macrophage	NULL
function	NULL
:	NULL
control	NULL
of	NULL
TNF-a	NULL
secretion	NULL
.	NULL

Inflamm	NULL
.	NULL

Res	NULL
.	NULL

46:447	NULL
.	NULL

Lew	NULL
,	NULL
W.	NULL
,	NULL
J.	NULL
J.	NULL
Oppenheim	NULL
,	NULL
and	NULL
K.	NULL
Matsusshima	NULL
.	NULL

1988	NULL
.	NULL

Analysis	NULL
of	NULL
the	NULL
suppression	NULL
of	NULL
IL-1a	NULL
and	NULL
IL-18	NULL
production	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
mononuclear	NULL
adherent	NULL
cells	NULL
by	NULL
a	NULL
glucocorticoid	NULL
hormone	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

140:1895	NULL
.	NULL

Breuninger	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
W.	NULL
L.	NULL
Dempsey	NULL
,	NULL
J.	NULL
Uhl	NULL
,	NULL
and	NULL
D.	NULL
M.	NULL
Murasko	NULL
.	NULL

1993	NULL
.	NULL

Hydrocortisone	NULL
regulation	NULL
of	NULL
interleukin-6	NULL
protein	NULL
production	NULL
by	NULL
a	NULL
purified	NULL
population	NULL
of	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

Clin	NULL
.	NULL

Immunol	NULL
.	NULL

Immunopathol	NULL
.	NULL

69:205	NULL
.	NULL

Lahm	NULL
,	NULL
H.	NULL
,	NULL
M.	NULL
Schindel	NULL
,	NULL
L.	NULL
Frikart	NULL
,	NULL
J.	NULL
P.	NULL
Cerottini	NULL
,	NULL
A.	NULL
Yilmaz	NULL
,	NULL
J.	NULL
C.	NULL
Givel	NULL
,	NULL
and	NULL
J.	NULL
R.	NULL
Fisher	NULL
.	NULL

1998	NULL
.	NULL

Selective	NULL
suppression	NULL
of	NULL
cytokine	NULL
secretion	NULL
in	NULL
whole	NULL
blood	NULL
cell	NULL
cultures	NULL
of	NULL
patients	NULL
with	NULL
colorectal	NULL
cancer	NULL
.	NULL

Br	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
78:1018	NULL
.	NULL

Murch	NULL
,	NULL
S.	NULL
H.	NULL
1998	NULL
.	NULL

Local	NULL
and	NULL
systemic	NULL
effects	NULL
of	NULL
macrophage	NULL
cytokines	NULL
in	NULL
intestinal	NULL
inflammation	NULL
.	NULL

Nutrition	NULL
14:780	NULL
.	NULL

Reder	NULL
,	NULL
A.	NULL
T.	NULL
,	NULL
K.	NULL
Gene	NULL
,	NULL
P.	NULL
V.	NULL
Byskosh	NULL
,	NULL
and	NULL
A.	NULL
M.	NULL
Porrini	NULL
.	NULL

1998	NULL
.	NULL

Monocyte	NULL
activation	NULL
in	NULL
multiple	NULL
sclerosis	NULL
.	NULL

Mult	NULL
.	NULL

Scler	NULL
.	NULL

4:162	NULL
.	NULL

Cohen	NULL
,	NULL
J.	NULL
J	NULL
.	NULL

1993	NULL
.	NULL

Apoptosis	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
14:126	NULL
.	NULL

Steller	NULL
,	NULL
H.	NULL
1995	NULL
.	NULL

Mechanisms	NULL
and	NULL
genes	NULL
of	NULL
cellular	NULL
suicide	NULL
.	NULL

Science	NULL
267:1445	NULL
.	NULL

Mangan	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
G.	NULL
R.	NULL
Welch	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Wahl	NULL
.	NULL

1991	NULL
.	NULL

Lipopolysaccharide	NULL
,	NULL
TNF-a	NULL
,	NULL
and	NULL
IL-1	NULL
3	NULL
prevent	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
in	NULL
human	NULL
peripheral	NULL
blood	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

146:1541	NULL
.	NULL

Mangan	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Wahl	NULL
.	NULL

1991	NULL
.	NULL

Differential	NULL
regulation	NULL
of	NULL
human	NULL
monocyte	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
by	NULL
chemotactic	NULL
factors	NULL
and	NULL
proinflammatory	NULL
cytokines	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

147:3408	NULL
.	NULL

Estaquier	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
J.	NULL
C.	NULL
Ameisen	NULL
.	NULL

1997	NULL
.	NULL

A	NULL
role	NULL
for	NULL
T-helper	NULL
type	NULL
1	NULL
and	NULL
type	NULL
2	NULL
cytokines	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
human	NULL
monocyte	NULL
apoptosis	NULL
.	NULL

Blood	NULL
90:1618	NULL
.	NULL

Mangan	NULL
,	NULL
D.	NULL
F.	NULL
,	NULL
B.	NULL
Robertson	NULL
,	NULL
and	NULL
S.	NULL
M.	NULL
Wahl	NULL
.	NULL

1992	NULL
.	NULL

IL-4	NULL
enhances	NULL
programmed	NULL
cell	NULL
death	NULL
(	NULL
apoptosis	NULL
)	NULL
in	NULL
stimulated	NULL
human	NULL
monocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

148:1812	NULL
.	NULL

Nicholson	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
A.	NULL
Ali	NULL
,	NULL
N.	NULL
A.	NULL
Thornberry	NULL
,	NULL
J.	NULL
P.	NULL
Vaillancourt	NULL
,	NULL
C.	NULL
K.	NULL
Ding	NULL
,	NULL
M.	NULL
Gallant	NULL
,	NULL
Y.	NULL
Gareau	NULL
,	NULL
P.	NULL
R.	NULL
Griffin	NULL
,	NULL
M.	NULL
Labelle	NULL
,	NULL
and	NULL
Y	NULL
.	NULL

A.	NULL
Lazebnik	NULL
.	NULL

1995	NULL
.	NULL

Identification	NULL
and	NULL
inhibition	NULL
of	NULL
the	NULL
ICE/CED-3	NULL
protease	NULL
necessary	NULL
for	NULL
mammalian	NULL
apoptosis	NULL
.	NULL

Nature	NULL
376:37	NULL
.	NULL

Nicholson	NULL
,	NULL
D.	NULL
W.	NULL
1996	NULL
.	NULL

ICE/CED3-like	NULL
proteases	NULL
as	NULL
therapeutic	NULL
targets	NULL
for	NULL
the	NULL
control	NULL
of	NULL
inappropriate	NULL
apoptosis	NULL
.	NULL

Nat	NULL
.	NULL

Biotechnol	NULL
.	NULL

14:297	NULL
.	NULL

Schlegel	NULL
,	NULL
J.	NULL
,	NULL
I.	NULL
Peters	NULL
,	NULL
S.	NULL
Orrenius	NULL
,	NULL
D.	NULL
K.	NULL
Miller	NULL
,	NULL
N.	NULL
A.	NULL
Thornberry	NULL
,	NULL
T.	NULL
T.	NULL
Yamin	NULL
,	NULL
and	NULL
D.	NULL
W.	NULL
Nicholson	NULL
.	NULL

1996	NULL
.	NULL

CPP32/apopain	NULL
is	NULL
a	NULL
key	NULL
interleukin	NULL
1B-converting	NULL
enzyme-like	NULL
protease	NULL
involved	NULL
in	NULL
Fas-mediated	NULL
apoptosis	NULL
.	NULL

J.	NULL
Biol	NULL
.	NULL

Chem	NULL
.	NULL

271	NULL
:	NULL
1841	NULL
.	NULL

Liu	NULL
,	NULL
Y.	NULL
,	NULL
J.	NULL
M.	NULL
Cousin	NULL
,	NULL
J.	NULL
Hughes	NULL
,	NULL
J.	NULL
V.	NULL
Damme	NULL
,	NULL
J.	NULL
R.	NULL
Seckl	NULL
,	NULL
C.	NULL
Haslett	NULL
,	NULL
I.	NULL
Dransfield	NULL
,	NULL
J.	NULL
Savill	NULL
,	NULL
and	NULL
A.	NULL
G.	NULL
Rossi	NULL
.	NULL

1999	NULL
.	NULL

Glucocorticoids	NULL
promote	NULL
nonphlo-gistic	NULL
phagocytosis	NULL
of	NULL
apoptotic	NULL
leukocytes	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

162:3639	NULL
.	NULL

Liigering	NULL
,	NULL
N.	NULL
,	NULL
T.	NULL
Kucharzik	NULL
,	NULL
A.	NULL
Liigering	NULL
,	NULL
G.	NULL
Winde	NULL
,	NULL
C.	NULL
Sorg	NULL
,	NULL
W.	NULL
Domschke	NULL
,	NULL
and	NULL
R.	NULL
Stoll	NULL
.	NULL

1997	NULL
.	NULL

Importance	NULL
of	NULL
combined	NULL
treatment	NULL
with	NULL
IL-10	NULL
and	NULL
IL-4	NULL
,	NULL
but	NULL
not	NULL
IL-13	NULL
,	NULL
for	NULL
inhibition	NULL
of	NULL
monocyte	NULL
release	NULL
of	NULL
the	NULL
Ca**-binding	NULL
protein	NULL
MRP8/14	NULL
.	NULL

Immunology	NULL
91:130	NULL
.	NULL

Heidenreich	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Schmidt	NULL
,	NULL
C.	NULL
August	NULL
,	NULL
P.	NULL
Cullen	NULL
,	NULL
A.	NULL
Rademaekers	NULL
,	NULL
and	NULL
H.	NULL
G.	NULL
Pauels	NULL
.	NULL

1997	NULL
.	NULL

Regulation	NULL
of	NULL
human	NULL
monocyte	NULL
apoptosis	NULL
by	NULL
the	NULL
CD14	NULL
mol-ecule	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

159:3178	NULL
.	NULL

Heidenreich	NULL
,	NULL
S.	NULL
,	NULL
M.	NULL
Schmidt	NULL
,	NULL
J.	NULL
Bachmann	NULL
,	NULL
and	NULL
B.	NULL
Harrach	NULL
.	NULL

1996	NULL
.	NULL

Apoptosis	NULL
of	NULL
monocytes	NULL
cultured	NULL
from	NULL
long-term	NULL
hemodialysis	NULL
patients	NULL
.	NULL

Kidney	NULL
Int	NULL
.	NULL

49:792	NULL
.	NULL

Beato	NULL
,	NULL
M.	NULL
1989	NULL
.	NULL

Gene	NULL
regulation	NULL
by	NULL
steroid	NULL
hormones	NULL
.	NULL

Cell	NULL
56:335	NULL
.	NULL

Werb	NULL
,	NULL
Z.	NULL
,	NULL
R.	NULL
Foley	NULL
,	NULL
and	NULL
A.	NULL
Munck	NULL
.	NULL

1978	NULL
.	NULL

Interaction	NULL
of	NULL
glucocorticoids	NULL
with	NULL
macrophages	NULL
:	NULL
identification	NULL
of	NULL
glucocorticoid	NULL
receptors	NULL
in	NULL
monocytes	NULL
and	NULL
macrophages	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

147:1684	NULL
.	NULL

Thompson	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
R.	NULL
van	NULL
Furth	NULL
.	NULL

1970	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
glucocorticosteroids	NULL
on	NULL
the	NULL
kinetics	NULL
of	NULL
mononuclear	NULL
phagocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

131:429	NULL
.	NULL

Waage	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
O.	NULL
Bakke	NULL
.	NULL

1988	NULL
.	NULL

Glucocorticoids	NULL
suppress	NULL
the	NULL
production	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
by	NULL
lipopolysaccharide-stimulated	NULL
human	NULL
monocytes	NULL
.	NULL

Immunology	NULL
63:299	NULL
.	NULL

Brunetti	NULL
,	NULL
M.	NULL
,	NULL
N.	NULL
Martelli	NULL
,	NULL
A.	NULL
Colasente	NULL
,	NULL
M.	NULL
Piantelli	NULL
,	NULL
P.	NULL
Musiani	NULL
,	NULL
and	NULL
F.	NULL
B.	NULL
Aiello	NULL
.	NULL

1995	NULL
.	NULL

Spontancous	NULL
and	NULL
glucocorticoid-induced	NULL
apoptosis	NULL
in	NULL
human	NULL
mature	NULL
T-lymphocytes	NULL
.	NULL

Blood	NULL
86:4199	NULL
.	NULL

Tuosto	NULL
,	NULL
L.	NULL
,	NULL
E.	NULL
Cundari	NULL
,	NULL
M.	NULL
S.	NULL
Montani	NULL
,	NULL
and	NULL
E.	NULL
Piccolella	NULL
.	NULL

1994	NULL
.	NULL

Analysis	NULL
of	NULL
susceptibility	NULL
of	NULL
mature	NULL
human	NULL
T-lymphocytes	NULL
to	NULL
dexamethasone-induced	NULL
apoptosis	NULL
.	NULL

Eur	NULL
.	NULL

J.	NULL
Immunol	NULL
.	NULL

24:1061	NULL
.	NULL

6107	NULL
'01	NULL
Aepy	NULL
uo	NULL
isan	NULL
$	NULL
4q	NULL
310	NULL
founwurrf'mmm//	NULL
:	NULL
dyy	NULL
wo	NULL
papeojumoG	NULL

